Village Farms International (VFF) 10-K/A 19 Mar 21 2020 FY Annual report (amended) Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 12, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	The purpose of this Amendment No. 1 on Form 10-K/A (this “Amendment No. 1”) to the Annual Report on Form 10-K (as amended, the “Annual Report”) of Village Farms International, Inc. (the “Company”) for the year ended December 31, 2020, originally filed with the Securities and Exchange Commission on March 16, 2021 (the “Original 10-K”), is (1) to file Exhibits 101.1 and 104.1 to the Annual Report in accordance with Rule 405 of Regulation S-T, which had been omitted from the Original 10-K on the basis of the temporary hardship exemption set forth in Rule 201 of Regulation S-T; and (2) to file as Exhibit 10.17 to the Annual Report the Third Amended and Restated Credit Agreement, dated as of March 15, 2021 (the “Third Amended and Restated PSF Credit Agreement”), by and between Pure Sunfarms Corp., Bank of Montreal, Farm Credit Canada and Canadian Imperial Bank of Commerce, which had been omitted from the Original 10-K as a result of the proximity in time of entering into the Third Amended and Restated PSF Credit Agreement to the filing date of the Original 10-K. The Third Amended and Restated PSF Credit Agreement extends the maturity date of the PSF Credit Facility and the PSF Term Loan (each as defined in the Original 10-K) by two years, includes an unlimited guarantee from Village Farms, limits the use of funds for capital expenditures and changes certain financial covenants. This disclosure has been added to Item 7, “Management’s Discussion and Analysis of Results of Operations and Financial Conditions – Liquidity and Capital Resources” to the Annual Report. In addition, the Company is including in this Amendment No. 1 updated certifications from its Chief Executive Officer and Chief Financial Officer as required by Sections 302 of the Sarbanes-Oxley Act of 2002 as Exhibits 31.1 and 31.2, respectively, and updated certifications from its Chief Executive Officer and Chief Financial Officer as required by Sections 906 of the Sarbanes-Oxley Act of 2002 as Exhibits 32.1 and 32.2, respectively. Except as described above, no other changes have been made to the Original 10-K. This Amendment No. 1 speaks as of the filing date of the Original 10-K, does not reflect events that may have occurred subsequent to such date, and does not modify or update in any way disclosures made in the Original 10-K.
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Trading Symbol	VFF
Entity Registrant Name	VILLAGE FARMS INTERNATIONAL, INC.
Entity Central Index Key	0001584549
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Well-known Seasoned Issuer	No
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Security Exchange Name	NASDAQ
Entity Address, Country	CA
Title of 12(b) Security	Common Shares, without par value
Entity File Number	001-38783
Entity Incorporation State Country Code	Z4
Entity Tax Identification Number	98-1007671
Entity Address, State or Province	BC
Entity Address, Address Line One	4700-80th Street
Entity Address, City or Town	Delta
Entity Address, Postal Zip Code	V4K 3N3
City Area Code	604
Local Phone Number	940-6012
Document Annual Report	true
Document Transition Report	false
ICFR Auditor Attestation Flag	false
Entity Common Stock, Shares Outstanding		79,596,193
Entity Public Float			$ 220,577,373

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 21,640	$ 11,989
Restricted cash (note 3)	4,039
Trade receivables, less allowance for doubtful accounts of $13 and $5	23,222	8,997
Inventories (note 4)	46,599	15,918
Amounts due from joint venture (note 14)		15,418
Other receivables	145	342
Income tax receivable	18	713
Prepaid expenses and deposits	6,145	1,259
Total current assets	101,808	54,636
Non-current assets
Property, plant and equipment (note 5)	187,020	63,158
Investments in joint ventures (notes 6 and 7)		41,334
Investments in minority interests (note 7)	1,226
Note receivable - joint venture (note 14)	3,545	10,865
Goodwill (note 6)	24,027
Intangibles (notes 6 and 8)	17,311
Deferred tax asset (note 15)	13,312	7,999
Operating right-of-use assets (note 11)	3,797	3,485
Finance right-of-use assets (note 11)	35	97
Other assets	1,950	1,834
Total assets	354,031	183,408
Current liabilities
Line of credit	2,000	2,000
Trade payables	15,064	12,653
Current maturities of long-term debt (note 9)	10,166	3,423
Note payable (note 9)	15,314
Accrued liabilities (note 10)	22,438	3,017
Operating lease liabilities - current (note 11)	1,107	875
Finance lease liabilities - current (note 11)	27	61
Income tax payable	4,523
Other current liabilities	1,641
Total current liabilities	72,280	22,029
Non-current liabilities
Long-term debt (note 9)	53,913	28,966
Deferred tax liability (note 15)	18,059	1,873
Operating lease liabilities - non-current (note 11)	2,855	2,690
Finance lease liabilities - non-current (note 11)	8	34
Other liabilities	1,633	1,357
Total liabilities	148,748	56,949
Commitments and contingencies (note 13)
SHAREHOLDERS’ EQUITY
Common stock, no par value per share - unlimited shares authorized; 66,911,811 shares issued and outstanding at December 31, 2020 and 52,656,669 shares issued and outstanding at December 31, 2019	145,668	98,333
Additional paid in capital	17,502	4,351
Accumulated other comprehensive loss	6,255	(475)
Retained earnings	35,858	24,250
Total shareholders’ equity	205,283	126,459
Total liabilities and shareholders’ equity	$ 354,031	$ 183,408

Consolidated Statements of Fi_2

Consolidated Statements of Financial Position (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Assets [Abstract]
Allowance for doubtful accounts receivable	$ 13	$ 5
Common stock, no par value
Common Stock, Shares, Issued	66,911,811	52,656,669
Common Stock, Shares, Outstanding	66,911,811	52,656,669

Condensed Consolidated Interim

Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Sales (note 16)	$ 170,086	$ 144,568	$ 150,000
Cost of sales	(159,126)	(151,913)	(140,683)
Gross margin (note 16)	10,960	(7,345)	9,317
Selling, general and administrative expenses	(19,086)	(16,762)	(14,108)
Share-based compensation	(6,142)	(4,714)	(1,454)
Interest expense (note 16)	(2,056)	(2,614)	(2,794)
Interest income (note 16)	625	1,036	311
Foreign exchange (loss) gain	(136)	433	(1,047)
Gain on settlement agreement (note 6)	4,681
Gain on acquisition (note 6)	23,631
Other income	49	268	131
(Loss) gain on disposal of assets	(922)	13,564
Loss on joint venture loans (note 7)	(3,791)	(1,184)
Income (loss) before taxes and earnings of unconsolidated entities	7,813	(17,318)	(9,644)
Recovery of income taxes	2,790	5,866	2,300
Income (loss) from consolidated entities after income taxes	10,603	(11,452)	(7,344)
Equity earnings from unconsolidated entities (notes 6 and 7)	1,005	13,777	(171)
Net income (loss)	$ 11,608	$ 2,325	$ (7,515)
Basic income (loss) per share (note 17)	$ 0.20	$ 0.05	$ (0.17)
Diluted income (loss) per share (note 17)	$ 0.19	$ 0.05	$ (0.17)
Weighted average number of common shares used in the computation of net income (loss) per share (in thousands):
Basic	58,526	49,418	44,357
Diluted	61,490	51,179	44,357
Net income (loss)	$ 11,608	$ 2,325	$ (7,515)
Other comprehensive income (loss):
Foreign currency translation adjustment	6,730	87	(171)
Comprehensive income (loss)	$ 18,338	$ 2,412	$ (7,686)

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Retained Earnings [Member]
Beggining Balance at Dec. 31, 2017	$ 66,890	$ 36,115	$ 1,726	$ (391)	$ 29,440
Beggining Balance (in shares) at Dec. 31, 2017		42,243
Shares issued in public offering, net of issuance costs	15,737	$ 15,737
Shares issued in pubic offering, net of issuance costs (in shares)		3,097
Shares issued in private placement of common shares, net of issuance costs	7,755	$ 7,755
Shares issued in private placement of common shares, net of issuance costs (in shares)		1,887
Shares issued on exercise of stock options (note 18)	283	$ 434	(151)
Shares issued on exercise of stock options (note 18) (in shares)		366
Share-based compensation (note 18)	1,454	$ 831	623
Share-based compensation (note 18) (in shares)		50
Cumulative translation adjustment	(171)			(171)
Net income (loss)	(7,515)				(7,515)
Ending Balance at Dec. 31, 2018	84,433	$ 60,872	2,198	(562)	21,925
Ending Balance (in shares) at Dec. 31, 2018		47,643
Shares issued in public offering, net of issuance costs	34,226	$ 34,226
Shares issued in pubic offering, net of issuance costs (in shares)		4,059
Shares issued on exercise of stock options (note 18)	208	$ 324	(116)
Shares issued on exercise of stock options (note 18) (in shares)		212
Share-based compensation (note 18)	4,714	$ 2,297	2,417
Share-based compensation (note 18) (in shares)		443
Shares issued on exercise of warrants	466	$ 614	(148)
Shares issued on exercise of warrants (in shares)		300
Cumulative translation adjustment	87			87
Net income (loss)	2,325				2,325
Ending Balance at Dec. 31, 2019	126,459	$ 98,333	4,351	(475)	24,250
Ending Balance (in shares) at Dec. 31, 2019		52,657
Shares issued in public offering, net of issuance costs	42,550	$ 42,550
Shares issued in pubic offering, net of issuance costs (in shares)		12,990
Warrants issued in public offering	11,369		11,369
Shares issued on exercise of stock options (note 18)	425	$ 692	(267)
Shares issued on exercise of stock options (note 18) (in shares)		1,265
Share-based compensation (note 18)	6,142	$ 4,093	2,049
Cumulative translation adjustment	6,730			6,730
Net income (loss)	11,608				11,608
Ending Balance at Dec. 31, 2020	$ 205,283	$ 145,668	$ 17,502	$ 6,255	$ 35,858
Ending Balance (in shares) at Dec. 31, 2020		66,912

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows provided by (used in) operating activities:
Net income (loss)	$ 11,608	$ 2,325	$ (7,515)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	6,825	7,366	7,027
Amortization of deferred charges	115	76	76
Share of (income) loss from joint venture (notes 5 and 6)	(1,005)	(13,777)	170
Loss on joint venture loans (note 6)	3,791	1,184
Interest expense	2,056	2,614	2,794
Interest income	(625)	(1,036)	(311)
Interest paid on long-term debt	(1,295)	(2,635)	(2,417)
Gain on settlement agreement	(4,681)
Loss (gain) on disposal of assets	922	(13,564)
Gain on acquisition of Pure Sunfarms	(23,631)
Non-cash lease expense	(1,150)	(1,043)
Interest paid on finance lease	(4)
Share-based compensation	6,142	4,714	1,454
Deferred income taxes	(6,462)	(5,855)	(2,730)
Changes in non-cash working capital items (note 19)	13,072	5,244	(3,225)
Net cash provided by (used in) operating activities	5,678	(14,387)	(4,677)
Cash flows used in investing activities:
Purchases of property, plant and equipment, net of rebate	(3,419)	(2,287)	(3,093)
Purchases of intangibles	(92)
Advances to joint ventures	(177)	(14,507)	(10,462)
Proceeds from sale of assets		52	65
Investment in joint ventures	(11,713)	(96)
Investment in minority interests	(1,226)
Acquisitions, net	(34,603)
Net cash used in investing activities	(51,230)	(16,838)	(13,490)
Cash flows provided by financing activities:
Proceeds from borrowings	10,619	4,000	7,000
Repayments on borrowings	(6,292)	(7,423)	(7,706)
Proceeds from issuance of common stock and warrants	57,212	35,030	23,635
Issuance costs	(3,293)	(338)	(143)
Proceeds from exercise of stock options	425	208	283
Payments on capital lease obligations	(63)	(90)	(71)
Net cash provided by financing activities	58,608	31,387	22,998
Effect of exchange rate changes on cash and cash equivalents	634	(93)	(2)
Net increase in cash and cash equivalents	13,690	69	4,829
Cash and cash equivalents, beginning of period	11,989	11,920	7,091
Cash and cash equivalents, end of period	25,679	11,989	11,920
Supplemental cash flow information:
Income taxes paid	$ 158	$ 904	$ 290

Nature of Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Nature of Operations	1 Village Farms International, Inc. (“VFF”) the parent company, together with its subsidiaries (collectively, the “Company”, “we”, “us”, or “our”) is incorporated under the Canada Business Corporation Act. VFF’s principal operating subsidiaries as of December 31, 2020 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), VF Clean Energy, Inc. (“VFCE”), and Pure Sunfarms Corp. (“Pure Sunfarms”). The address of the registered office of VFF is 4700 80th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 65% equity interest in Village Fields Hemp USA LLC (“VF Hemp”), which is recorded as an equity investment (note 7). The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also listed in the United States on the Nasdaq Capital Market (“Nasdaq”) under the symbol VFF. The Company owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia (“B.C.”) and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company, through its subsidiary Pure Sunfarms, is a licensed producer and supplier of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. The Company’s joint venture, VF Hemp was a cultivator of high cannabidiol (“CBD”) hemp in multiple states throughout the United States. Coronavirus Pandemic (“COVID-19”) In March 2020, the World Health Organization declared the outbreak of the COVID-19 virus a global pandemic. This outbreak continues to cause major disruptions to businesses and markets worldwide as the virus continues to spread. Several countries as well as certain states and cities within the United States and Canada have enacted temporary closures of businesses, issued quarantine or shelter-in-place orders and taken other restrictive measures. In response to the COVID-19 pandemic, the Company implemented safety protocols and procedures to protect its employees, its subcontractors, and its customers. These protocols include complying with social distancing and other health and safety standards as mandated by state and local government agencies, taking into consideration guidance from the Centers for Disease Control and Prevention and other public health authorities. In April 2020, the Government of Canada announced the Canada Emergency Wage Subsidy (“CEWS”) to help Canadian businesses to keep employees on the payroll in response to the challenges posed by the COVID-19 pandemic. During 2020, Pure Sunfarms determined that it met the employer eligibility criteria and applied for the CEWS and received C$2,470 of wage subsidies during the year ended December 31, 2020. Currently, all of the Company’s operations are operating normally, however, the extent to which COVID-19 and the related global economic crisis affect the Company’s business, results of operations and financial condition, will depend on future developments that are highly uncertain and cannot be predicted, including the scope and duration of the pandemic and any recovery period, future actions taken by governmental authorities, central banks and other third parties (including new financial regulation and other regulatory reform) in response to the pandemic, and the effects on our produce, clients, vendors and employees. Village Farms continues to service its customers amid uncertainty and disruption linked to COVID-19 and is actively managing its business to respond to the impact.

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	2 Basis of Presentation The accompanying audited Consolidated Financial Statements for the year ended December 31, 2020 have been prepared in accordance with United States generally accepted accounting principles (“US GAAP”) and the following accounting policies have been consistently applied in the preparation of the Consolidated Financial Statements. Principles of Consolidation The Company’s consolidated financial statements include the accounts of its wholly owned subsidiaries. The Company consolidates variable interest entities (“VIEs”) when it has variable interests and is the primary beneficiary. The Company continually evaluates its involvement with VIEs to determine when these criteria are met. All intercompany transactions, balances and unrealized gains and losses from intercompany transactions are eliminated when consolidated. Functional and Presentation Currency The functional currency for each entity included in these consolidated financial statements is the currency of the primary economic environment in which the entity operates. These consolidated financial statements are presented in United States dollars (“U.S. dollars”) which have been rounded to the nearest thousands, except share and per share amounts or when otherwise noted . Currency conversion to U.S. dollars is performed in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 830, Foreign Currency Matters .

Significant Accounting Policies

Significant Accounting Policies, Judgments and Estimation Uncertainty	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies, Judgments and Estimation Uncertainty	3 The significant accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements. Use of Estimates The preparation of the Company’s financial statements in accordance with US GAAP requires the Company to make estimates and assumptions that affect the amounts reported in its consolidated financial statements and accompanying notes. Actual results could differ from these estimates and those differences could be material. Cash and Cash Equivalents Cash and cash equivalents consist of cash deposits held with banks, and other highly liquid short-term interest-bearing securities with maturities at the date of purchase of three months or less. Restricted Cash Restricted cash consists of cash reserved as a guarantee to support a letter of credit. T rade Receivables Trade receivables, net of the allowance for doubtful accounts, represent their estimated net realizable value, which approximates fair value. Provisions for doubtful accounts are recorded based on historical collection experience and the age of the receivables. Receivables are written off when they are deemed uncollectible. Inventories Inventories, consisting of available for sale flower and trim, distilled oil, crop inventory, capitalized production costs and purchased produce inventory are valued at the lower of cost or net realizable value. The cost of inventory includes capitalized production costs, including labor, materials, post-harvest costs and depreciation. Other inventory, including seed and packaging materials, and spare parts are valued at the lower of cost or net realizable value. Inventoriable costs are expensed to cost of goods sold on the consolidated statement of income (loss) in the same period as finished products are sold. The amount of any write-down of inventories to net realizable value and all losses of inventories are recognized as an expense in the period when the write-down or loss occurs. Short-term Deposits Short-term deposits consist primarily of a security deposit for excise tax. Intangible Assets The Company’s intangible assets are purchased and acquired through business combinations and have both finite and infinite useful lives. They are measured at cost less accumulated amortization and any accumulated impairment losses. Amortization is calculated based on the cost of the intangible assets less their estimated residual values using the straight-line method over their estimated useful lives and is generally recognized in profit or loss. Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted when necessary. Classification Estimated Useful Lives Licenses 22 years Brand Indefinite Computer Software 5 years Business Combinations The Company recognizes and measures the assets acquired and liabilities assumed in a business combination based on their estimated fair values at the acquisition date, while transaction and integration costs related to business combinations are expensed as incurred. Any excess of the purchase consideration when compared to the fair value of the net tangible and intangible assets acquired, if any, is recorded as goodwill. The Company uses information available to it t o make fair value determinations and engage independent valuation specialists, when necessary, to assist in the fair value determination of significant acquired long-lived assets. The estimated fair value of licenses is determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand is determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires considerable judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software is generally valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. If the initial accounting for the business combination is incomplete by the end of the reporting period in which the acquisition occurs, an estimate is recorded. Subsequent to the acquisition date, and not later than one year from the acquisition date, the Company will record any material adjustments to the initial estimate based on new information obtained that would have existed as of the date of the acquisition. Any adjustment that arises from information obtained that did not exist as of the date of acquisition will be recorded in the period the adjustments arise. Goodwill Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired in a business acquisition. Goodwill is allocated to reporting units and tested for impairment annually as of December 31 each year and when events or changes in circumstances indicate that the carrying value of a reporting unit exceeds its fair value. The Company generally elects to utilize the optional qualitative assessment for goodwill to determine whether it is more likely than not that the carrying value of a reporting unit is higher than its fair value. If it is determined that the fair value is more likely than not to be lower than the carrying value, a quantitative goodwill impairment test is performed by determining the fair value of the reporting unit. The fair value of a reporting unit is determined using either the income approach utilizing estimates of discounted future cash flows or the market approach utilizing recent transaction activity for comparable properties. These approaches are considered level 3 fair value measurements. If the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. Equity Method Investments and Variable Interest Entities The Company evaluates the method of accounting for investments in which it does not hold an equity interest of at least 50% based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Investments not qualifying for consolidation are accounted for under the equity method whereby the ongoing investment in the entity, consisting of its initial investment adjusted for distributions, gains and losses of the entity are classified as a single line in the consolidated statements of financial position and as a non-operating item in the consolidated statements of income (loss). The Company regularly monitors and evaluates the fair value of its equity investments. If events and circumstances indicate that a decline in the fair value of these assets has occurred and is other than temporary, the Company will record a charge in earnings from joint ventures in the consolidated statements of income (loss). The Company’s investments do not have a readily determinable fair value as none of them are publicly traded. The fair values of the Company’s equity investments are determined by discounting the estimated future cash flows of each entity. These cash flow estimates include assumptions on growth rates and future currency exchange rates (Level 3). The Company did not record an impairment charge on any of its equity investments in fiscal years 2020, 2019, or 2018, except as noted in Note 6. Property, Plant and Equipment a) Recognition and measurement Property, plant and equipment is initially recorded at cost. Cost includes expenditures that are directly attributable to the acquisition of the asset. Directly attributable costs incurred for major capital projects and site preparation are capitalized until the asset is brought to the location and condition necessary for it to be used in the manner intended by management. The cost of self-constructed assets includes the cost of materials and direct labour, any other costs directly attributable to bringing the assets to a working condition for their intended use, the costs of dismantling and removing the items and restoring the site on which they are located and borrowing costs. Where an item of property, plant and equipment comprises significant components with different useful lives, the components are accounted for as separate items of property, plant and equipment. Expenditures incurred to replace a component of an item of property, plant and equipment that is accounted for separately, including major inspection and overhaul expenditures, are capitalized. Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost can be measured reliably. Repairs and maintenance costs are charged to the consolidated statement of income (loss) and comprehensive income (loss) during the period in which they are incurred. Items of property, plant and equipment acquired in a non-monetary transaction are measured at fair value, unless the transaction has no commercial substance or the fair value of both the asset received and the asset given up cannot be reliably measured. If an item of property, plant and equipment acquired in a non-monetary transaction cannot be measured at fair value, it is measured at the carrying amount of the asset given up in the exchange. Subsequent to initial recognition, property, plant and equipment is stated at cost less accumulated depreciation and accumulated impairment losses. The gain or loss on disposal of an item of property, plant and equipment is determined by comparing the proceeds from disposal with the carrying amount of the property, plant and equipment, and is presented net within gain/loss on disposal of assets in the consolidated statement of income (loss) and comprehensive income (loss). b) Depreciation Depreciation is based on the cost of an asset less its residual value. Significant components of individual assets are assessed, and if a component has a useful life that is different from the remainder of that asset, that component is depreciated separately. Depreciation expense is recognized on a straight-line basis over the estimated useful lives of each component of an item of property, plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the Company will obtain ownership by the end of the lease term. Land is not depreciated. Classification Estimated Useful Lives Leasehold and land improvements 5-20 years Greenhouses and other buildings 4-30 years Greenhouse equipment 3-30 years Machinery and equipment 3-20 years Construction in process reflects the cost of assets under construction, which are not depreciated until placed into service. Revenue Recognition Following the adoption of ASC 606 on January 1, 2018 using the modified retrospective transition approach the Company now recognizes revenue when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. In order to achieve this core principle, the Company applies a five-step process. The Company generates its revenue through the sale of grown produce and third-party produce, with standard shipping terms and discounts, and through the production and sale of power. The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods at a fixed price. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders they receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and their performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns. Revenue from the sale of cannabis inventories in the course of ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts, volume rebates and excise duty. The Company recognizes revenue when it has fulfilled the performance obligation to the customer through the delivery and transfer of control of the promised goods. The amount of revenue recognized is reduced by excise duty, estimated returns and other customer credits, such as discounts and rebates. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is still in the Company’s physical possession, and title and risk of loss has passed to the customer. Revenue is recognized when all specific requirements for transfer of control under a bill-and-hold arrangement have been met. The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption. The Company has elected to exclude taxes collected from its customers assessed by government authorities that are both imposed on and concurrent with a specific revenue-producing transaction from our determination of transaction price. Revenue received from shipping and handling fees is reflected in net sales. Shipping and handling costs are included in cost of sales as incurred or at the time revenue is recognized for the related goods, whichever comes first. Impairments of Long-Lived Assets Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Long-lived assets are grouped with other assets to the lowest level to which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Management assesses the recoverability of the carrying cost of the assets based on a review of projected undiscounted cash flows. If an asset is held for sale, management reviews its estimated fair value less cost to sell. Fair value is determined using pertinent market information, including appraisals or broker’s estimates, and/or projected discounted cash flows. In the event an impairment loss is identified, it is recognized based on the amount by which the carrying value exceeds the estimated fair value of the long-lived asset. Segment Reporting Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (“CEO”). Based on the aggregation criteria in ASC Topic 280, Segment Reporting Foreign Currency Translation Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency at the exchange rates in effect at the reporting date. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated to the functional currency at the exchange rate in effect when the fair value was determined. Foreign currency differences are generally recognized in net income. Non-monetary items that are measured based on historical cost in a foreign currency are translated to the functional currency using the exchange rate in effect at the date of the transaction giving rise to the item. Fair Value Measurements Pursuant to the provisions of ASC 820, Fair Value Measurements and Disclosures The three levels are defined as follows: Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Observable inputs, other than those included in Level 1, based on quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in inactive markets. Level 3: Unobservable inputs that reflect an entity’s own assumptions about what inputs a market participant would use in pricing the asset or liability based on the best information available in the circumstances. Transfers between levels of the fair value hierarchy are deemed to have occurred at the end of the reporting period in which the event or change of circumstances caused the transfer to occur. Share-Based Compensation The Company grants stock options and performance-based restricted stock (“RS”) to certain employees and directors. The Company recognizes stock-based compensation using the fair value provisions prescribed by ASC Topic 718, Compensation — Stock Compensation Stock options generally vest over three years (33% per year following the grant date) and expire after ten years. Each tranche in an award is considered a separate award with its own vesting period. The fair value of each tranche is measured at the date of grant using the Black-Scholes option pricing model. Compensation expense is recognized over the tranche’s vesting period by increasing additional paid-in capital based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately. The RS granted will be settled using the Company’s own equity and issued from treasury if the performance standard is met. The equity-settled share-based compensation is measured at the fair value of the Company’s common shares as at the grant date in accordance with the terms of the Company’s Stock Compensation Plan. The fair value determined at the grant date is charged to income when performance-based vesting conditions are met, based on the number of RS that will eventually be converted to common shares, with a corresponding increase in equity. Income Taxes Deferred income taxes are provided to recognize temporary differences between the financial reporting basis and the income tax basis of the Company’s assets and liabilities using currently enacted tax rates and laws. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. The Company evaluates uncertain income tax positions in a two-step process. The first step is recognition, where the Company evaluates whether an individual tax position has a likelihood of greater than 50% of being sustained upon examination based on the technical merits of the position, including resolution of any related appeals or litigation processes. For tax positions that are currently estimated to have a less than 50% likelihood of being sustained, zero tax benefit is recorded. For tax positions that have met the recognition threshold in the first step, the Company performs the second step of measuring the benefit to be recorded. The actual benefits ultimately realized may differ from the Company’s estimates. In future periods, changes in facts and circumstances and new information may require the Company to change the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recorded in results of operations and financial position in the period in which such changes occur. Basic and Diluted Income (Loss) Per Share Basic income per share is computed using the weighted average number of common shares outstanding during the period. The treasury stock method is used for the calculation of diluted income per share. Under this method, the weighted average number of common shares outstanding assumes that the proceeds to be received on the exercise of dilutive share options are applied to repurchase common shares at the average market price for the period. Share options are dilutive when the average market price of the common shares during the period exceeds the exercise price of the options. Options to purchase shares of common stock and RS are not included in the calculation of net income (loss) per share when the effect is anti-dilutive. Government Assistance Government assistance is recorded as a receivable when the Company qualifies under the terms of a government program and the amount of the assistance can be reasonably estimated. Government assistance for current expenses is recorded in cost of sales and selling, general and administrative expenses. New Accounting Pronouncements Not Yet Adopted In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Adopted In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820)—Disclosure Framework— Changes to the Disclosure Requirements for Fair Value Measurement.” In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses.”

Inventories

Inventories	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventories	4 Inventories consisted of the following: December 31, 2020 December 31, 2019 Cannabis: Available for sale - flower and trim $ 12,720 $ - Distilled oil 13,511 — Capitalized production costs 3,438 — Other 2,552 — Produce and Energy: Crop inventory 13,441 15,281 Purchased produce inventory 810 530 Spare parts inventory 127 107 Inventory $ 46,599 $ 15,918 As of December 31, 2020 and 2019, crop inventory was also impaired by nil and $218, respectively, to its net realizable value.

Property Plant And Equipment

Property Plant And Equipment	12 Months Ended
	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Property Plant And Equipment	5 Property, plant and equipment consist of the following: Classification December 31, 2020 December 31, 2019 Land $ 10,447 $ 3,204 Leasehold and land improvements 4,154 3,820 Buildings 142,060 72,772 Machinery and equipment 69,390 61,871 Construction in progress 52,960 1,697 Less: Accumulated depreciation (91,991 ) (80,206 ) Property, plant and equipment, net $ 187,020 $ 63,158 Depreciation expense on property, plant and equipment, was $6,703, $7,366 and $7,027 for the years ending December 31, 2020, 2019 and 2018, respectively.

Pure Sunfarms Acquisitions

Pure Sunfarms Acquisitions	12 Months Ended
	Dec. 31, 2020
Business Combinations [Abstract]
Pure Sunfarms Acquisitions	6 which was repaid in full on February 8, 2021 (note 20). The acquisition is a business combination and has been accounted for in accordance with the measurement and recognition provisions of ASC Topic 805, Business Combinations The Company used information available to make fair value determinations and engaged independent valuation specialists to assist in the fair value determination of acquired intangible assets. The estimated fair value of licenses was determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand was determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires considerable judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software was valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. The initial accounting for the business combination was considered complete for the year ended December 31, 2020. The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables $ 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 Pro Forma Financial Information (unaudited) The following unaudited pro forma financial information presents consolidated results assuming the Pure Sunfarms Acquisition occurred on January 1, 2019. December 31, 2020 December 31, 2019 Sales $ 214,181 $ 206,909 Net income (loss) (1) $ (1,817 ) $ 31,475 (1) The net income figures above include the impact of the $23.6 million gain on acquisition and the impact of the fair value adjustments to inventory through cost of sales, as well as the elimination of historical equity earnings related to Pure Sunfarms. Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, in accordance with ASC 323 – Equity Method and Joint Ventures During the period ending November 1, 2020, the Company was required to apply the hypothetical liquidation at book value (“HLBV”) method to determine its allocation of the profits and losses in Pure Sunfarms. When determining its allocation of profits and losses, the HLBV method only considers shares that have been fully paid for. Under the hypothetical liquidation method, the Company received 58.7% and 54.0% of Pure Sunfarms’ earnings for the period ending November 1, 2020 and the year ending December 31, 2019, respectively. On March 31, 2019, Pure Sunfarms exercised its option to utilize the Delta 2 assets and operations. The contribution of the assets has been accounted for as a disposal of the land, greenhouse facility and other assets in exchange for 25,000,000 common shares of Pure Sunfarms. This was a non-cash transaction, and it was estimated that the fair value of the land, building and other assets was $18.7 million (C$25.0 million) at the date of contribution. The Company recognized a gain of $13.6 million on the contribution of the fixed assets. On March 2, 2020, pursuant to the settlement agreement with Emerald (the “Settlement Agreement”), Emerald transferred to the Company 2.5% of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be $4.7 million (C$6.5 million). The Company recorded this amount as a gain on settlement agreement in the Condensed Consolidated Interim Statement of Income (Loss) and Comprehensive Income (Loss) for the year ended December 31, 2020. In addition, Village Farms made additional equity contributions to Pure Sunfarms of C$16.0 (US$11.7) million in 2020, further increasing its majority ownership of Pure Sunfarms to 58.7% from 57.4%. The Company’s share of the joint venture consists of the following: Balance, January 1, 2019 $ 6,341 Investments in joint venture 18,717 Share of net income for the year 16,276 Balance, December 31, 2019 $ 41,334 Balance, January 1, 2020 $ 41,334 Investments in joint venture 16,393 Share of net income for the year 4,980 Balance, November 1, 2020 $ 62,707 Summarized financial information of Pure Sunfarms: November 1, 2020 December 31, 2019 Current assets Cash and cash equivalents $ 10,804 $ 7,356 Trade receivables 10,499 8,687 Inventory 33,330 21,745 Other current assets 4,234 6,964 Non-current assets 119,415 108,652 Current liabilities Trade payables (3,829 ) (4,938 ) Borrowings due to joint ventures (10,912 ) (26,413 ) Income taxes payable — (8,489 ) Borrowings - current (2,294 ) (1,423 ) Other current liabilities (15,381 ) (5,021 ) Non-current liabilities Borrowings – long term (23,780 ) (13,089 ) Deferred tax liability (11,391 ) (2,473 ) Net assets $ 110,695 $ 91,558 Reconciliation of net assets: Accumulated retained earnings $ 35,310 $ 26,679 Contributions from joint venture partners 75,738 63,481 Currency translation adjustment (353 ) 1,398 Net assets $ 110,695 $ 91,558 November 1, 2020 December 31, 2019 December 31, 2018 Revenue $ 44,097 $ 62,341 $ 3,691 Cost of sales* (27,038 ) (15,067 ) (1,154 ) Gross margin 17,059 47,274 2,537 Selling, general and administrative expenses (8,717 ) (7,882 ) (2,584 ) Income (loss) from operations 8,342 39,392 (47 ) Interest expense (947 ) (884 ) (72 ) Foreign exchange gain (loss) (209 ) (9 ) (176 ) Write down of fixed assets — (144 ) — Other income, net** 4,223 26 18 Income (loss) before taxes 11,409 38,381 (277 ) Provision for income taxes (2,778 ) (10,967 ) 55 Net income (loss) $ 8,631 $ 27,414 $ (222 ) *Included in cost of sales for the period ended November 1, 2020 and years ended December 31, 2019 and 2018 is $3,120, $2,671 and $796 of depreciation expense. **The period ended November 1, 2020 includes a gain recognized on the settlement of net liabilities.

Investment In Joint Ventures An

Investment In Joint Ventures And Minority Interests	12 Months Ended
	Dec. 31, 2020
Equity Method Investments And Joint Ventures [Abstract]
Investment In Joint Ventures And Minority Interests	7 INVESTMENT IN JOINT VENTURES AND MINORITY INTERESTS Village Fields Hemp USA LLC On February 27, 2019, the Company entered into a joint venture with Nature Crisp, LLC (“Nature Crisp”) to form VF Hemp for the objective of outdoor cultivation of high percentage CBD hemp and CBD extraction in multiple states throughout the United States. VF Hemp is 65% owned by the Company and 35% owned by Nature Crisp. The Company accounts for its investment in VF Hemp, in accordance with ASC 323, using the equity method. The Company has determined that VF Hemp is a VIE, however it does not consolidate VF Hemp because the Company is not the primary beneficiary. Although the Company was able to exercise significant influence over the operating and financial policies of VF Hemp through its 65% ownership interest and joint power arrangement with Nature Crisp, the Company shares joint control of the Board of Directors and therefore is not the primary beneficiary. The Company’s maximum exposure to loss as a result of its involvement with VF Hemp relates directly to the recovery of the outstanding loan to VF Hemp of $3,545. On March 25, 2019, the Company entered into a Grid Loan Agreement (the “Grid Loan”) with VF Hemp. The Grid Loan has a maturity date of March 25, 2022 and bears simple interest at the rate of 8% per annum, calculated monthly. During the fourth quarter of 2020, VF Hemp wrote its inventory to net realizable value and recognized a loss of $5,163. As a result of the inventory write-down, the Company also recognized an impairment of $3,791 on the outstanding grid loan with VF Hemp. As of December 31, 2020, the balance of the grid loan was $3,545 (note 14). The Company is not legally obligated for the debts, obligations or liabilities of VF Hemp. Summarized financial information of VF Hemp: December 31, 2020 December 31, 2019 Current assets Inventory $ 4,035 $ 9,308 Other current assets 302 546 Non-current assets 937 1,476 Current liabilities (1,472 ) (1,788 ) Non-current liabilities (13,697 ) (13,323 ) Net assets $ (9,895 ) $ (3,781 ) Reconciliation of net assets: Accumulated retained earnings $ (3,791 ) $ (3,791 ) Net loss for the year ended December 31, 2020 (6,114 ) — Contributions from joint venture partners 10 10 Net assets $ (9,895 ) $ (3,781 ) December 31, 2020 December 31, 2019 Revenue $ 348 $ 106 Cost of sales (482 ) (121 ) Depreciation (244 ) (111 ) General and administrative expenses (631 ) (869 ) Interest expense (345 ) (440 ) Write down of inventory (5,038 ) (2,356 ) Other 278 — Net loss $ (6,114 ) $ (3,791 ) Arkansas Valley Green and Gold Hemp On May 21, 2019, the Company entered into a joint venture with Arkansas Valley Hemp, LLC (“AV Hemp”) for the objective of outdoor cultivation of high percentage CBD hemp and CBD extraction in Colorado. The joint venture, AVGG Hemp, was 60% owned by the Company, 35% owned by AV Hemp, and 5% owned by VF Hemp. Subsequent to year end, all of the hemp was destroyed by a severe windstorm. As a result of the loss, the Company wrote off its $1,184 loan to AVGG Hemp during the year ended December 31, 2019. Minority Interest During 2020 the Company acquired minority interests in two international companies in order to leverage its experience and expand into international cannabis and CBD opportunities. In July 2020, the Company invested $226, for an approximate 16% minority interest ownership in DutchCanGrow Inc. (“DCG”), a Netherlands-based cannabis enterprise. In August 2020, the Company invested $1,000 for a 6.6% minority interest ownership in Australia-based Altum International Pty Ltd (“Altum”), with an option to increase its ownership in Altum on similar terms. On February 8, 2021, the Company exercised an option to increase the equity investment of Altum from 6.6% to just under 10%. Altum is a cannabinoid platform with a focus on the distribution and marketing of CBD products in the Asia-Pacific region.

Intangibles

Intangibles	12 Months Ended
	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Intangibles	8 Acquired intangibles consist of the following: Classification December 31, 2020 Licenses $ 12,870 Branding 3,688 Computer software 945 Less: Accumulated amortization (192 ) Intangibles, net $ 17,311 The expected future amortization expense for definite-lived intangible assets as of December 31, 2020 is as follows: Fiscal period 2021 $ 777 2022 777 2023 771 2024 771 2025 680 Thereafter 9,847 Intangibles, net $ 13,623 Amortization expense for intangibles was $122 for the year ending December 31, 2020.

Debt

Debt	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt	9 Balance outstanding as of December 31, 2020 2019 Term Loan - ("FCC Loan") - repayable by monthly principle of payments of $164 and accrued interest at a rate of 3.79%; matures April 1, 2025 $ 28,690 $ 31,306 Term Loan - VFCE: CA$3.0M - non-revolving fixed rate loan with fixed interest rate of 4.98%; matures June 2023 797 1,066 Advance on term loan - VFCE: CA$250 - repayable in monthly installments of principle plus interest rate of CA$ prime rate plus 200 basis points 69 106 Term Loan - Pure Sunfarms - CA$19.0M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount, interest rate of 4.2%; matures February, 2022 13,385 — Term loan - Pure Sunfarms - CA$25.0 - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount starting June 30, 2021, interest rate of 4.2%; matures February 2022 16,535 — BDC Facility - Pure Sunfarms - non-revolving demand loan at prime interest plus 3.75% 4,905 — Unamortized deferred financing fees (302 ) (89 ) Total $ 64,079 $ 32,389 The Company has a line of credit agreement with a Canadian Chartered Bank (“Operating Loan”). The revolving Operating Loan has a line of credit up to C$13,000, less outstanding letters of credit totaling US$150 and C$38, and variable interest rates with a maturity date on May 31, 2021. The Operating Loan is subject to margin requirements stipulated by the bank. As of December 31, 2020 and December 31, 2019, the amount drawn on this facility was US$2,000. As collateral for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities), and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at December 31, 2020 and 2019 was $86,664 and $155,548, respectively. As collateral for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therein. The carrying value of the assets pledged as collateral as at December 31, 2020 and 2019 was $23,443 and $24,915, respectively. The Company’s borrowings (“Credit Facilities”), excluding Pure Sunfarms borrowings, are subject to certain positive and negative covenants, including debt ratios, and the Company is required to maintain certain minimum working capital. In December 2020, the Company amended the terms of its covenants with respect to its FCC Loan. The amended covenants have been waived for the year ending December 31, 2020 and will be reinstated for fiscal year 2021. As of December 31, 2020, the Company was in compliance with all of its other Credit Facility covenants under its Credit Facilities. Pure Sunfarms entered into a revolving line of credit on June 30, 2020 with a Canadian chartered bank up to a maximum of $15,000. Interest is payable at the Canadian prime rate plus an applicable margin. As of December 31, 2020, no advances were made on this facility. On December 31, 2020, the Company had outstanding a $4,039 letter of credit issued to BC Hydro against the revolving line of credit. The term loan held by the Company’s subsidiary Pure Sunfarms of C$17.5 million (US$13.3 million) was entered into on February 7, 2019 and amended on June 30, 2020 and is secured by a first-ranking security interest in respect of all present and future property, assets and undertakings of the Company. The term loan held by the Company’s subsidiary Pure Sunfarms of C$22.5 million (US$16.5 million) was entered into on April 2, 2020 and amended on June 30, 2020 and is secured by a first-ranking security interest in respect of all present and future property, assets and undertakings of the Company. On December 20, 2020 Pure Sunfarms entered into a C$6,250 non-revolving demand loan at prime interest plus 3.75% with a Canadian Chartered Bank with the financial support of the Business Development Bank of Canada (the “BDC Facility”). The BDC Facility, provided as part of COVID-19 relief, requires interest only payments monthly for the first twelve months, and commencing December 31, 2021 and maturing December 31, 2031, Pure Sunfarms will repay the outstanding principal amount in equal monthly installments. The outstanding amount on the loan was US$4,905 on December 31, 2020. Pure Sunfarms is required to comply with financial covenants, measured quarterly. The Company has a note payable due to Emerald Health of C$19.9 million (US$15.2 million), plus accrued interest in the statement of financial position that it originally issued to Emerald as partial consideration for the November 2, 2020 acquisition of Pure Sunfarms. The note and accrued interest were repaid to Emerald Health in full on February 8, 2020 (note 20). The weighted average interest rate on short-term borrowings as of December 31, 2020 and 2019 was 5.11% and 6.2%, respectively. Accrued interest payable on the credit facilities and loans as of December 31, 2020 and 2019 was $189 and $162, respectively, and these amounts are included in accrued liabilities in the statements of financial position. The aggregate annual principal maturities of long-term debt for the next five years and thereafter are as follows: 2021 $ 7,187 2022 29,909 2023 2,960 2024 2,760 2025 22,297 Thereafter 3,468 $ 68,581

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2020
Payables And Accruals [Abstract]
Accrued Liabilities	10 December 31, 2020 December 31, 2019 Accrued taxes $ 12,071 $ 527 Accrued payroll 2,865 296 Other 7,502 2,194 $ 22,438 $ 3,017

Leases

Leases	12 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Leases	1 1 The Company leases a parcel of land in Marfa, Texas that one of its greenhouses resides on as well as two distribution centers located in Fort Worth, Texas and Surrey, British Columbia. The Company also leases production related equipment at its greenhouses in Texas and British Columbia. In January 2020, the Company commenced leasing of an office building located in Lake Mary, Florida for its corporate headquarters. The components of lease related expenses are as follows: Year ended December 31, 2020 2019 Operating lease expense (a) $ 2,244 $ 2,410 Finance lease expense: Amortization of right-of-use assets 63 80 Interest on lease liabilities 4 7 Total finance lease expense $ 67 $ 87 (a) Includes short-term lease costs of $461 and $1,287 for the year ended December 31, 2020 and 2019 Cash paid for amounts included in the measurement of lease liabilities: Year ended December 31, 2020 2019 Operating cash flows from operating leases $ 1,150 $ 1,043 Operating cash flows from finance leases $ 4 $ — Financing cash flows from finance leases $ 63 $ 90 December 31, 2020 Weighted average remaining lease term: Operating leases 4.3 years Finance leases 1.2 years Weighted average discount rate: Operating leases 5.75 % Finance leases 6.25 % Maturities of lease liabilities are as follows: Operating leases Finance leases 2021 $ 1,304 $ 30 2022 1,090 9 2023 870 — 2024 512 — 2025 258 — Thereafter — — Undiscounted lease cash flow commitments 4,034 39 Reconciling impact from discounting (72 ) (4 ) Lease liabilities on consolidated balance sheet as of December 31, 2020 $ 3,962 $ 35

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 31, 2020
Investments All Other Investments [Abstract]
Financial Instruments	12 Financial assets and liabilities are recognized on the consolidated statements of financial position at fair value in a hierarchy for those assets and liabilities measured at fair value on a recurring basis. At December 31, 2020 and 2019, the Company’s financial instruments included cash and cash equivalents, trade receivables, note receivables, minority investments, trade payables, accrued liabilities, lease liabilities, note payables and debt. The carrying value of cash and cash equivalents, trade receivables, trade payables, and accrued liabilities approximate their fair values due to the short-term maturity of these financial instruments. The carrying value of lease liabilities, notes payable, and debt approximate their fair values due to insignificant changes in credit risk. There were no financial instruments categorized as Level 3 at December 31, 2020 and December 31, 2019, other than the minority investments discussed below. There were no transfers of assets or liabilities between levels during the years ended December 31, 2020 and 2019, respectively. For its minority investments, the Company has elected the practicability election to fair value measurement, under which the investment is measured at cost, less impairment, plus or minus any observable price changes of an identical or similar investment.

Commitments And Contingencies

Commitments And Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	1 3 In the normal course of business, the Company and its subsidiaries may become defendants in certain employment claims and other litigation. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. The Company is not involved in any legal proceedings other than routine litigation arising in the normal course of business, none of which the Company believes will have a material adverse effect on the Company’s business, financial condition or results of operations. At December 31, 2020, Pure Sunfarms had a commitment of $1,000 in the event of a service agreement break up.

Related Party Transactions and

Related Party Transactions and Balances	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transaction and Balances	1 4 On March 25, 2019, the Company entered into a Grid Loan Agreement (the “Grid Loan”) with VF Hemp. The Grid Loan has a maturity date of March 25, 2022 and bears simple interest at the rate of 8% per annum, calculated monthly. As of December 31, 2020, and December 31, 2019 the Grid Loan balance was $3,545 and $10,865, respectively. VF Hemp recognized a loss on inventory due to a write-down to net realizable value. As a result of the loss, the Company wrote down $3,791 of its loan to VF Hemp to $3,545. Under the terms of the AVGG Hemp Joint Venture Agreement, the Company agreed to lend approximately $5 million to AVGG Hemp for start-up costs and working capital. The loan bore simple interest at the rate of 8% per annum, calculated monthly. As of December 31, 2019, the Company had loaned AVGG Hemp approximately $ 1,184 . Immediately following AVGG Hemp’s 2019 fourth quarter harvest, all of the hemp was destroyed by a severe windstorm. As a result of the loss, the Company wrote off its $ 1,184 loan to AVGG Hemp during the year ended December 31, 2019 . One of the Company’s employees is related to a member of the Company’s executive management team and received approximately $118, $110 and $115 in salary and benefits during the years ended December 31, 2020, 2019 and 2018, respectively. As of December 31, 2020, the Company had advanced $249 to an employee in connection with a relocation at the request of the Company, which was included in other assets on the Consolidated Statement of Financial Position. In January 2021, the employee repaid $124 of the outstanding loan balance. The remaining balance will be forgiven following on year of service with the Company.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	1 5 The components of the provision for (recovery of) income tax for the years ended December 31, 2020, 2019 and 2018 are as follows: 2020 Current Deferred Total US Federal $ — $ (4,879 ) $ (4,879 ) US State 260 (434 ) (174 ) Canadian 3,412 (1,149 ) 2,263 $ 3,672 $ (6,462 ) $ (2,790 ) 2019 Current Deferred Total US Federal $ — $ (5,922 ) $ (5,922 ) US State 8 (751 ) (743 ) Canadian (19 ) 818 799 $ (11 ) $ (5,855 ) $ (5,866 ) 2018 Current Deferred Total US Federal $ — $ (1,786 ) $ (1,786 ) US State 8 (187 ) (179 ) Canadian 422 (757 ) (335 ) $ 430 $ (2,730 ) $ (2,300 ) The provision for (recovery of) income taxes reflected in the consolidated statements of (loss) income for the years ended December 31, 2020, 2019 and 2018 differs from the amounts computed at the federal statutory tax rates. The principal differences between the statutory income tax (recovery) and the effective provision for (recovery of) income taxes are summarized as follows: Year Ended December 31, 2020 2019 2018 Income (loss) before income taxes $ 8,818 $ (3,541 ) $ (9,815 ) Tax (recovery) calculated at US domestic tax rates 1,869 (744 ) (2,061 ) State tax adjustments (310 ) (350 ) — Non-deductible items (6,531 ) 1,304 394 True up of prior year income tax estimates (181 ) 207 (206 ) Capitalized debt amortization costs — (631 ) — Share of (income) losses from joint venture (228 ) (4,367 ) (75 ) Unrealized foreign exchange — (276 ) (309 ) Deferred adjustment 343 (1,920 ) — Differences attributed to joint venture capital transactions — (487 ) — Tax rate differences on deferred items 49 (42 ) (56 ) Differences in Canadian tax rates 1,643 1,472 92 Change in tax rates 37 — — Change in valuation allowance 3 (144 ) — Other 516 112 (79 ) Provision for (recovery of) income taxes $ (2,790 ) $ (5,866 ) $ (2,300 ) The statutory tax rate in effect in Canada and the United States for the years ended December 31, 2020, 2019 and 2018 was 27.0% and 21.0%, respectively. The blended effective tax rate for 2020 was (31.4%) Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets and liabilities presented on the consolidated statements of financial position are net amounts corresponding to their reporting jurisdiction. The deferred tax assets and liabilities presented in the note disclosure are grouped based on asset and liability classification without consideration of their corresponding reporting jurisdiction. Significant components of the Company’s net deferred income taxes at December 31, 2020 and 2019 are as follows: 2020 2019 Deferred tax assets: Other assets $ 4,935 $ 2,536 Long-term debt 897 1,040 Tax losses: Non-capital and farm losses 14,336 11,553 Provisions: Debt and unit issuance costs 1,355 800 Joint venture shares — 1,154 Tax losses: Valuation allowance (35 ) (31 ) 21,488 17,052 Deferred tax liabilities: Joint venture shares (2,651 ) (2,593 ) Cash adjustment (7,604 ) — Property, plant and equipment (15,980 ) (8,333 ) (26,235 ) (10,926 ) Net tax assets $ (4,747 ) $ 6,126 In assessing the ability to realize deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon available positive and negative evidence and future taxable income, the Company has recorded a $3 5 valuation allowance on their deferred tax assets for the year ended December 31, 2020 . The valuation allowance reflected on the consolidated balance sheets is approximately $ , $ and $ 504 at December 31, 2020 , 2019 and 2018 respectively. Included in the schedule of deferred tax assets and liabilities above are US federal net operating losses carryforwards of approximately $58,780 and $48,285 as of December 31, 2020 and 2019, respectively, which will begin to expire in 2031. At the state level, the Company has a combined state net operating loss carry forward of approximately $21,108 and $12,572 as of December 31, 2020 and 2019, respectively, which started to expire in 2020. The Canadian Non-Capital Losses carry forwards are $3,345 and $1,770 as of December 31, 2020 and 2019, respectively, which will begin to expire in 2027. At December 31, 2020 and 2019, the balance of uncertain tax benefits is zero. The Company does not anticipate that the amount of the uncertain tax benefit will significantly increase within the next 12 months. The Company recognizes accrued interest related to uncertain tax benefits and penalties as income tax expense. As of December 31, 2020 and 2019, there are no recognized liabilities for interest or penalties. The Company is subject to taxation in the U.S. and various states, as well as Canada and its provinces. As of December 31, 2020, the Company’s tax years for 2017, 2018 and 2019 are subject to examination by the tax authorities. As of December 31, 2020, the Company is no longer subject to U.S. federal, state or local examinations by tax authorities for years before 2016.

Segment and Geographic Informat

Segment and Geographic Information	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Segment and Geographic Information	1 6 Segment reporting is prepared on the same basis that the Company’s Chief Executive Officer, who is the Company’s Chief Operating Decision Maker, manages the business, makes operating decisions and assesses performance. Management has determined that the Company operates in three segments. The Company’s three segments include Cannabis, Produce and Energy. The Cannabis segment produces and supplies cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. The Produce segment produces, markets, and sells premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer. For years ended December 31, 2020 and 2019, approximately 79% and 83%, respectively, of the Company’s total sales were in the United States. In 2020 the Company had two customers that individually represented more than 10% of total sales, comprising of 12.7% and 12.5% of sales, respectively. In 2019 the Company had three customers that individually represented more than 10% of its sales, comprising of 11.8%, 10.9% and 10.6% of sales, respectively. As of December 31, 2020, the Company’s trade receivables had two customers that represented more than 10 % of the balance of trade receivables, representing 26.3 % of the balance. As of December 31, 2019, the Company’s trade receivables had one customer that represented more than 10 % of the balance of trade receivables, representing 16.9 % of the balance. The Company believes that its expected credit losses are limited due to the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represents the majority of the Company’s annual sales and accounts receivable at year end. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables of the debtor). The Company’s primary operations are in the United States and Canada. Segment information as of and for the years ended December 31, 2020, 2019 and 2018: 2020 2019 2018 Sales Produce $ 156,891 $ 143,419 $ 148,054 Cannabis – Canada 12,778 — — Energy – Canada 417 1,149 1,946 $ 170,086 $ 144,568 $ 150,000 Interest expense Produce $ 1,759 $ 2,543 $ 2,705 Cannabis – Canada 243 — — Energy – Canada 54 71 89 $ 2,056 $ 2,614 $ 2,794 Interest income Corporate $ 623 $ 1,036 $ 311 Cannabis – Canada 2 — — $ 625 $ 1,036 $ 311 Depreciation and amortization Produce $ 5,356 $ 6,462 $ 6,155 Cannabis – Canada 822 — — Energy – Canada 647 904 872 $ 6,825 $ 7,366 $ 7,027 Gross margin Produce $ 9,621 $ (6,667 ) $ 9,153 Cannabis – Canada 2,193 — — Energy – Canada (854 ) (678 ) 164 $ 10,960 $ (7,345 ) $ 9,317 Total assets 2020 2019 United States $ 110,107 $ 180,462 Canada 243,924 2,946 $ 354,031 $ 183,408 Property, plant and equipment, net 2020 2019 United States $ 56,011 $ 60,415 Canada 131,009 2,743 $ 187,020 $ 63,158

Income (Loss) Per Share

Income (Loss) Per Share	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Income (Loss) Per Share	1 7 Basic net income (loss) per share is computed using the weighted average number of common shares outstanding for the period. Basic and diluted net income per ordinary share is calculated as follows (shares in thousands): For the Years Ended December 31, (shares in thousands) 2020 2019 2018 Numerator: Net income (loss) $ 11,608 $ 2,325 $ (7,515 ) Denominator: Weighted average number of common shares – Basic 58,526 49,418 44,357 Effect of dilutive securities – share-based employee options and awards 2,964 1,761 — Weighted average number of common shares – Diluted 61,490 51,179 44,357 Antidilutive options and awards (1) 500 310 2,175 Net income (loss) per ordinary share: Basic $ 0.20 $ 0.05 $ (0.17 ) Diluted $ 0.19 $ 0.05 $ (0.17 ) (1) Options to purchase shares of common stock and unvested RSUs are not included in the calculation of net income (loss) per share because the effect would have been anti-dilutive.

Shareholders Equity and Share B

Shareholders Equity and Share Based Compensation	12 Months Ended
	Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Shareholders Equity and Share Based Compensation	1 8 On September 10, 2020 the Company closed a registered direct offering with certain institutional investors for the purchase and sale of an aggregate of 9,396,226 units at a purchase price of $5.30 per unit for gross proceeds of approximately $49.8 million before placement agent fees and other offering expenses. Each unit that was sold consists of one common share of the Company and a one-half (0.5) of a warrant to purchase a common share of the Company at an exercise price of $5.80. The warrants will be exercisable beginning on March 10, 2021 and will expire on September 10, 2025. ASC 480, Distinguishing Liabilities from Equity The Company’s Share-Based Compensation Plan (the “Plan”), dated January 1, 2010 was most recently approved by Shareholders on June 14, 2018. The Plan provides that the number of Common Shares reserved for issuance upon the exercise or redemption of awards granted under the Plan is a rolling maximum of ten percent (10%) of the outstanding Common Shares at any point in time. Approximately 2,175,000 shares remain available for issuance at December 31, 2020. Stock options have been granted with an exercise price equal to the fair market value of the common stock on the date of grants and have a ten-year The fair market value of stock options is estimated using the Black-Scholes-Merton valuation model and the Company uses the following methods to determine its underlying assumptions: expected volatilities are based on the historical volatilities of the weekly closing price of the Company’s common stock; the expected term of options granted is based historical exercises and forfeitures; the risk-free interest rate is based on Canadian Treasury bonds issued with similar life terms to the expected life of the grant; and the expected dividend yield is based on the current annual dividend amount divided by the stock price on the date of grant. Forfeitures are recorded when incurred. The following key assumptions were used in the valuation model to value stock option grants for each respective period: 2020 2019 2018 Expected volatility 71.1 % 60.7 % 55.5 % Dividend $nil $nil $nil Risk-free interest rate 0.52 % 1.86 % 2.30 % Expected life 7.1 years 5.7 years 5.9 years Fair value C$5.8314 C$9.7259 C$3.2541 Stock option transactions under the Company’s plan for the years ended December 31, 2020, 2019 and 2018 are summarized as follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value Outstanding at January 1, 2018 2,337,732 C$1.59 5.89 $ 14,125 Granted during 2018 203,000 C$5.79 9.44 Exercised during 2018 (365,733 ) C$0.98 2.68 Forfeited/expired during 2018 (10,000 ) C$1.48 Outstanding at December 31, 2018 2,164,999 C$2.10 5.69 $ 5,553 Exercisable at December 31, 2018 1,648,670 C$1.43 4.74 $ 5,012 Granted during 2019 510,000 C$16.32 9.19 Exercised during 2019 (212,332 ) C$1.29 4.85 Forfeited during 2019 (10,001 ) C$2.20 Outstanding at December 31, 2019 2,452,666 C$5.12 5.60 $ 11,435 Exercisable at December 31, 2019 1,707,337 C$1.78 4.18 $ 10,736 Granted 1,081,488 C$8.77 9.75 Exercised (425,166 ) C$1.36 1.62 Forfeited (41,666 ) C$6.93 — Outstanding at December 31, 2020 3,067,322 C$6.91 6.82 $ 20,051 Exercisable at December 31, 2020 1,618,168 C$3.91 4.58 $ 15,119 The weighted-average grant-date fair value of options granted during the years 2020, 2019 and 2018 was $5.83, $9.58 and $3.22, respectively. The total intrinsic value of options exercised during the years ended December 31, 2020, 2019 and 2018, was $2,732, $1,999 and $2,162, respectively. A summary of the status of the Company’s non-vested stock options, and the changes during the year ended December 31, 2020, is presented below: Number of Options Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Non-vested at January 1, 2020 745,329 C$7.43 Granted 1,081,488 C$5.83 Vested (362,664 ) C$6.36 Forfeited (14,999 ) C$6.05 Non-vested at December 31, 2020 1,449,154 C$6.52 C$4,931 As of December 31, 2020, there was $9,449 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the stock option plan; that cost is expected to be recognized over a period of three years. The Company has also issued performance-based restricted share units to Village Farms employees involved with future developments of the Company. Once a performance target is met and the share units are deemed earned and vested, compensation expense is recognized, based on the fair value of the share units on the grant date. Performance-based restricted share unit activity for the years ended December 31, 2020, 2019 and 2018 is as follows: Number of Performance-based Restricted Share Units Weighted Average Grant Date Fair Value Outstanding at January 1, 2018 128,000 C$2.82 Granted 979,000 C$5.79 Received (50,334 ) C$3.06 Forfeited/expired — — Outstanding at December 31, 2018 1,056,666 C$5.56 Exercisable at December 31, 2018 175,333 C$5.08 Granted 355,000 C$14.94 Issued (442,666 ) C$7.82 Forfeited (230,000 ) C$12.90 Outstanding at December 31, 2019 739,000 C$7.92 Exercisable at December 31, 2019 30,000 C$12.87 Granted 1,068,000 C$6.36 Exercised (840,000 ) C$6.47 Forfeited/expired (98,000 ) C$9.59 Outstanding at December 31, 2020 869,000 C$7.51 Exercisable at December 31, 2020 75,000 C$6.10 A summary of the status of the Company’s non-vested performance-based restricted share units, and the changes during the year ended December 31, 2020, is presented below: Number of Performance-based Restricted Share Units Weighted Average Grant Date Fair Value Non-vested at January 1, 2020 709,000 C$7.72 Granted 1,068,000 C$6.36 Vested (885,000 ) C$6.93 Forfeited (98,000 ) C$9.59 Non-vested at December 31, 2020 794,000 C$7.33 Total share-based compensation expense for the years ended December 31, 2020, 2019 and 2018 of $6,142, $4,714 and $1,454, respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to additional paid in capital.

Changes in Non-Cash Working Cap

Changes in Non-Cash Working Capital Items	12 Months Ended
	Dec. 31, 2020
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Changes in Non Cash Working Capital Items	1 9 For the Years Ended December 31, 2020 2019 2018 Trade receivables $ (3,196 ) $ 2,301 $ (33 ) Inventories 2,997 9,042 (5,435 ) Note Receivable 765 — — Due from joint ventures 4,363 (3,530 ) — Other receivables 199 (448 ) 1,239 Prepaid expenses and deposits (1,245 ) (370 ) (79 ) Trade payables (1,665 ) (1,953 ) 1,649 Accrued liabilities 6,565 (369 ) (284 ) Other assets, net of other liabilities 4,289 571 (282 ) $ 13,072 $ 5,244 $ (3,225 )

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	20 On January 20, 2021, the Company closed its registered direct offering with certain institutional investors for the purchase and sale of an aggregate of 10,887,097 common shares at a purchase price of US$12.40 (approximately C$15.70) per unit for gross proceeds of approximately US$135 million (approximately C$171 million) before placement agent fees and other offering expenses. The net proceeds from this offering are intended to be used for general working capital purposes. Upon closing of the offering there were 77,798,908 issued and outstanding common shares of Village Farms. On February 5, 2021, the Company repaid in full the C$19.9 million (approximately US$15.6 million) promissory note, plus accrued interest of C$622 (approximately US$487), that it originally issued to Emerald as partial consideration for the November 2020 acquisition from Emerald of the 36,958,500 common shares of Pure Sunfarms that Village Farms did not own. On September 10, 2020, the Company sold 9,396,226 units through a registered direct offering. Each unit that was sold consists of one common share of the Company and a one-half (0.5) of a warrant to purchase a common share of the Company at a price of US$5.80. On March 10, 2021 the warrants became exercisable, and they will expire on September 10, 2025. On March 10, 2021 1,773,585 of the warrants were exercised. Effective March 15, 2021, Pure Sunfarms renewed its aggregate loan facility with two Canadian chartered banks and Farm Credit Canada. The renewal extends the maturity date by two years, includes an unlimited guarantee from Village Farms, limits the use of funds for capital expenditures and changes certain financial covenants.

Significant Accounting Polici_2

Significant Accounting Policies, Judgments and Estimation Uncertainty (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying audited Consolidated Financial Statements for the year ended December 31, 2020 have been prepared in accordance with United States generally accepted accounting principles (“US GAAP”) and the following accounting policies have been consistently applied in the preparation of the Consolidated Financial Statements.
Principles of Consolidation	Principles of Consolidation The Company’s consolidated financial statements include the accounts of its wholly owned subsidiaries. The Company consolidates variable interest entities (“VIEs”) when it has variable interests and is the primary beneficiary. The Company continually evaluates its involvement with VIEs to determine when these criteria are met.
Foreign Currency	Functional and Presentation Currency The functional currency for each entity included in these consolidated financial statements is the currency of the primary economic environment in which the entity operates. These consolidated financial statements are presented in United States dollars (“U.S. dollars”) which have been rounded to the nearest thousands, except share and per share amounts or when otherwise noted . Currency conversion to U.S. dollars is performed in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 830, Foreign Currency Matters .
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in accordance with US GAAP requires the Company to make estimates and assumptions that affect the amounts reported in its consolidated financial statements and accompanying notes. Actual results could differ from these estimates and those differences could be material.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash deposits held with banks, and other highly liquid short-term interest-bearing securities with maturities at the date of purchase of three months or less.
Restricted Cash	Restricted Cash Restricted cash consists of cash reserved as a guarantee to support a letter of credit.
Trade Receivables	T rade Receivables Trade receivables, net of the allowance for doubtful accounts, represent their estimated net realizable value, which approximates fair value. Provisions for doubtful accounts are recorded based on historical collection experience and the age of the receivables. Receivables are written off when they are deemed uncollectible.
Inventories	Inventories Inventories, consisting of available for sale flower and trim, distilled oil, crop inventory, capitalized production costs and purchased produce inventory are valued at the lower of cost or net realizable value. The cost of inventory includes capitalized production costs, including labor, materials, post-harvest costs and depreciation. Other inventory, including seed and packaging materials, and spare parts are valued at the lower of cost or net realizable value. Inventoriable costs are expensed to cost of goods sold on the consolidated statement of income (loss) in the same period as finished products are sold. The amount of any write-down of inventories to net realizable value and all losses of inventories are recognized as an expense in the period when the write-down or loss occurs.
Short Term Deposits	Short-term Deposits Short-term deposits consist primarily of a security deposit for excise tax.
Intangible Assets	Intangible Assets The Company’s intangible assets are purchased and acquired through business combinations and have both finite and infinite useful lives. They are measured at cost less accumulated amortization and any accumulated impairment losses. Amortization is calculated based on the cost of the intangible assets less their estimated residual values using the straight-line method over their estimated useful lives and is generally recognized in profit or loss. Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted when necessary. Classification Estimated Useful Lives Licenses 22 years Brand Indefinite Computer Software 5 years
Business Combinations	Business Combinations The Company recognizes and measures the assets acquired and liabilities assumed in a business combination based on their estimated fair values at the acquisition date, while transaction and integration costs related to business combinations are expensed as incurred. Any excess of the purchase consideration when compared to the fair value of the net tangible and intangible assets acquired, if any, is recorded as goodwill. The Company uses information available to it t o make fair value determinations and engage independent valuation specialists, when necessary, to assist in the fair value determination of significant acquired long-lived assets. The estimated fair value of licenses is determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand is determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires considerable judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software is generally valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. If the initial accounting for the business combination is incomplete by the end of the reporting period in which the acquisition occurs, an estimate is recorded. Subsequent to the acquisition date, and not later than one year from the acquisition date, the Company will record any material adjustments to the initial estimate based on new information obtained that would have existed as of the date of the acquisition. Any adjustment that arises from information obtained that did not exist as of the date of acquisition will be recorded in the period the adjustments arise.
Goodwill	Goodwill Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired in a business acquisition. Goodwill is allocated to reporting units and tested for impairment annually as of December 31 each year and when events or changes in circumstances indicate that the carrying value of a reporting unit exceeds its fair value. The Company generally elects to utilize the optional qualitative assessment for goodwill to determine whether it is more likely than not that the carrying value of a reporting unit is higher than its fair value. If it is determined that the fair value is more likely than not to be lower than the carrying value, a quantitative goodwill impairment test is performed by determining the fair value of the reporting unit. The fair value of a reporting unit is determined using either the income approach utilizing estimates of discounted future cash flows or the market approach utilizing recent transaction activity for comparable properties. These approaches are considered level 3 fair value measurements. If the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
Equity Method Investments and Variable Interest Entities	Equity Method Investments and Variable Interest Entities The Company evaluates the method of accounting for investments in which it does not hold an equity interest of at least 50% based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee. Investments not qualifying for consolidation are accounted for under the equity method whereby the ongoing investment in the entity, consisting of its initial investment adjusted for distributions, gains and losses of the entity are classified as a single line in the consolidated statements of financial position and as a non-operating item in the consolidated statements of income (loss). The Company regularly monitors and evaluates the fair value of its equity investments. If events and circumstances indicate that a decline in the fair value of these assets has occurred and is other than temporary, the Company will record a charge in earnings from joint ventures in the consolidated statements of income (loss). The Company’s investments do not have a readily determinable fair value as none of them are publicly traded. The fair values of the Company’s equity investments are determined by discounting the estimated future cash flows of each entity. These cash flow estimates include assumptions on growth rates and future currency exchange rates (Level 3). The Company did not record an impairment charge on any of its equity investments in fiscal years 2020, 2019, or 2018, except as noted in Note 6.
Property, Plant and Equipment	Property, Plant and Equipment a) Recognition and measurement Property, plant and equipment is initially recorded at cost. Cost includes expenditures that are directly attributable to the acquisition of the asset. Directly attributable costs incurred for major capital projects and site preparation are capitalized until the asset is brought to the location and condition necessary for it to be used in the manner intended by management. The cost of self-constructed assets includes the cost of materials and direct labour, any other costs directly attributable to bringing the assets to a working condition for their intended use, the costs of dismantling and removing the items and restoring the site on which they are located and borrowing costs. Where an item of property, plant and equipment comprises significant components with different useful lives, the components are accounted for as separate items of property, plant and equipment. Expenditures incurred to replace a component of an item of property, plant and equipment that is accounted for separately, including major inspection and overhaul expenditures, are capitalized. Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost can be measured reliably. Repairs and maintenance costs are charged to the consolidated statement of income (loss) and comprehensive income (loss) during the period in which they are incurred. Items of property, plant and equipment acquired in a non-monetary transaction are measured at fair value, unless the transaction has no commercial substance or the fair value of both the asset received and the asset given up cannot be reliably measured. If an item of property, plant and equipment acquired in a non-monetary transaction cannot be measured at fair value, it is measured at the carrying amount of the asset given up in the exchange. Subsequent to initial recognition, property, plant and equipment is stated at cost less accumulated depreciation and accumulated impairment losses. The gain or loss on disposal of an item of property, plant and equipment is determined by comparing the proceeds from disposal with the carrying amount of the property, plant and equipment, and is presented net within gain/loss on disposal of assets in the consolidated statement of income (loss) and comprehensive income (loss). b) Depreciation Depreciation is based on the cost of an asset less its residual value. Significant components of individual assets are assessed, and if a component has a useful life that is different from the remainder of that asset, that component is depreciated separately. Depreciation expense is recognized on a straight-line basis over the estimated useful lives of each component of an item of property, plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the Company will obtain ownership by the end of the lease term. Land is not depreciated. Classification Estimated Useful Lives Leasehold and land improvements 5-20 years Greenhouses and other buildings 4-30 years Greenhouse equipment 3-30 years Machinery and equipment 3-20 years Construction in process reflects the cost of assets under construction, which are not depreciated until placed into service.
Revenue Recognition	Revenue Recognition Following the adoption of ASC 606 on January 1, 2018 using the modified retrospective transition approach the Company now recognizes revenue when control of the promised goods or services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. In order to achieve this core principle, the Company applies a five-step process. The Company generates its revenue through the sale of grown produce and third-party produce, with standard shipping terms and discounts, and through the production and sale of power. The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods at a fixed price. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders they receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and their performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns. Revenue from the sale of cannabis inventories in the course of ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts, volume rebates and excise duty. The Company recognizes revenue when it has fulfilled the performance obligation to the customer through the delivery and transfer of control of the promised goods. The amount of revenue recognized is reduced by excise duty, estimated returns and other customer credits, such as discounts and rebates. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is still in the Company’s physical possession, and title and risk of loss has passed to the customer. Revenue is recognized when all specific requirements for transfer of control under a bill-and-hold arrangement have been met. The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption. The Company has elected to exclude taxes collected from its customers assessed by government authorities that are both imposed on and concurrent with a specific revenue-producing transaction from our determination of transaction price. Revenue received from shipping and handling fees is reflected in net sales. Shipping and handling costs are included in cost of sales as incurred or at the time revenue is recognized for the related goods, whichever comes first.
Impairments of Long-Lived Assets	Impairments of Long-Lived Assets Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Long-lived assets are grouped with other assets to the lowest level to which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Management assesses the recoverability of the carrying cost of the assets based on a review of projected undiscounted cash flows. If an asset is held for sale, management reviews its estimated fair value less cost to sell. Fair value is determined using pertinent market information, including appraisals or broker’s estimates, and/or projected discounted cash flows. In the event an impairment loss is identified, it is recognized based on the amount by which the carrying value exceeds the estimated fair value of the long-lived asset.
Segment Reporting	Segment Reporting Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (“CEO”). Based on the aggregation criteria in ASC Topic 280, Segment Reporting
Foreign Currency Translation	Foreign Currency Translation Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency at the exchange rates in effect at the reporting date. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated to the functional currency at the exchange rate in effect when the fair value was determined. Foreign currency differences are generally recognized in net income. Non-monetary items that are measured based on historical cost in a foreign currency are translated to the functional currency using the exchange rate in effect at the date of the transaction giving rise to the item.
Fair Value Measurements	Fair Value Measurements Pursuant to the provisions of ASC 820, Fair Value Measurements and Disclosures The three levels are defined as follows: Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Observable inputs, other than those included in Level 1, based on quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in inactive markets. Level 3: Unobservable inputs that reflect an entity’s own assumptions about what inputs a market participant would use in pricing the asset or liability based on the best information available in the circumstances. Transfers between levels of the fair value hierarchy are deemed to have occurred at the end of the reporting period in which the event or change of circumstances caused the transfer to occur.
Share-Based Compensation	Share-Based Compensation The Company grants stock options and performance-based restricted stock (“RS”) to certain employees and directors. The Company recognizes stock-based compensation using the fair value provisions prescribed by ASC Topic 718, Compensation — Stock Compensation Stock options generally vest over three years (33% per year following the grant date) and expire after ten years. Each tranche in an award is considered a separate award with its own vesting period. The fair value of each tranche is measured at the date of grant using the Black-Scholes option pricing model. Compensation expense is recognized over the tranche’s vesting period by increasing additional paid-in capital based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately. The RS granted will be settled using the Company’s own equity and issued from treasury if the performance standard is met. The equity-settled share-based compensation is measured at the fair value of the Company’s common shares as at the grant date in accordance with the terms of the Company’s Stock Compensation Plan. The fair value determined at the grant date is charged to income when performance-based vesting conditions are met, based on the number of RS that will eventually be converted to common shares, with a corresponding increase in equity.
Income Taxes	Income Taxes Deferred income taxes are provided to recognize temporary differences between the financial reporting basis and the income tax basis of the Company’s assets and liabilities using currently enacted tax rates and laws. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. The Company evaluates uncertain income tax positions in a two-step process. The first step is recognition, where the Company evaluates whether an individual tax position has a likelihood of greater than 50% of being sustained upon examination based on the technical merits of the position, including resolution of any related appeals or litigation processes. For tax positions that are currently estimated to have a less than 50% likelihood of being sustained, zero tax benefit is recorded. For tax positions that have met the recognition threshold in the first step, the Company performs the second step of measuring the benefit to be recorded. The actual benefits ultimately realized may differ from the Company’s estimates. In future periods, changes in facts and circumstances and new information may require the Company to change the recognition and measurement estimates with regard to individual tax positions. Changes in recognition and measurement estimates are recorded in results of operations and financial position in the period in which such changes occur.
Basic and Diluted Income (Loss) Per Share	Basic and Diluted Income (Loss) Per Share Basic income per share is computed using the weighted average number of common shares outstanding during the period. The treasury stock method is used for the calculation of diluted income per share. Under this method, the weighted average number of common shares outstanding assumes that the proceeds to be received on the exercise of dilutive share options are applied to repurchase common shares at the average market price for the period. Share options are dilutive when the average market price of the common shares during the period exceeds the exercise price of the options. Options to purchase shares of common stock and RS are not included in the calculation of net income (loss) per share when the effect is anti-dilutive.
Government Assistance	Government Assistance Government assistance is recorded as a receivable when the Company qualifies under the terms of a government program and the amount of the assistance can be reasonably estimated. Government assistance for current expenses is recorded in cost of sales and selling, general and administrative expenses.
New Accounting Pronouncements	New Accounting Pronouncements Not Yet Adopted In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Adopted In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820)—Disclosure Framework— Changes to the Disclosure Requirements for Fair Value Measurement.” In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses.”

Significant Accounting Polici_3

Significant Accounting Policies, Judgments and Estimation Uncertainty (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Estimated Useful Lives of Intangible Assets	Classification Estimated Useful Lives Licenses 22 years Brand Indefinite Computer Software 5 years
Schedule of Tangible Assets Useful Life	Classification Estimated Useful Lives Leasehold and land improvements 5-20 years Greenhouses and other buildings 4-30 years Greenhouse equipment 3-30 years Machinery and equipment 3-20 years

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consisted of the following: December 31, 2020 December 31, 2019 Cannabis: Available for sale - flower and trim $ 12,720 $ - Distilled oil 13,511 — Capitalized production costs 3,438 — Other 2,552 — Produce and Energy: Crop inventory 13,441 15,281 Purchased produce inventory 810 530 Spare parts inventory 127 107 Inventory $ 46,599 $ 15,918

Property Plant And Equipment (T

Property Plant And Equipment (Tables)	12 Months Ended
	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment consist of the following: Classification December 31, 2020 December 31, 2019 Land $ 10,447 $ 3,204 Leasehold and land improvements 4,154 3,820 Buildings 142,060 72,772 Machinery and equipment 69,390 61,871 Construction in progress 52,960 1,697 Less: Accumulated depreciation (91,991 ) (80,206 ) Property, plant and equipment, net $ 187,020 $ 63,158

Pure Sunfarms Acquisitions (Tab

Pure Sunfarms Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2020
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables $ 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information presents consolidated results assuming the Pure Sunfarms Acquisition occurred on January 1, 2019. December 31, 2020 December 31, 2019 Sales $ 214,181 $ 206,909 Net income (loss) (1) $ (1,817 ) $ 31,475
Summary of company share of the joint venture	The Company’s share of the joint venture consists of the following: Balance, January 1, 2019 $ 6,341 Investments in joint venture 18,717 Share of net income for the year 16,276 Balance, December 31, 2019 $ 41,334 Balance, January 1, 2020 $ 41,334 Investments in joint venture 16,393 Share of net income for the year 4,980 Balance, November 1, 2020 $ 62,707
Pure Sunfarms
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	Summarized financial information of Pure Sunfarms: November 1, 2020 December 31, 2019 Current assets Cash and cash equivalents $ 10,804 $ 7,356 Trade receivables 10,499 8,687 Inventory 33,330 21,745 Other current assets 4,234 6,964 Non-current assets 119,415 108,652 Current liabilities Trade payables (3,829 ) (4,938 ) Borrowings due to joint ventures (10,912 ) (26,413 ) Income taxes payable — (8,489 ) Borrowings - current (2,294 ) (1,423 ) Other current liabilities (15,381 ) (5,021 ) Non-current liabilities Borrowings – long term (23,780 ) (13,089 ) Deferred tax liability (11,391 ) (2,473 ) Net assets $ 110,695 $ 91,558 Reconciliation of net assets: Accumulated retained earnings $ 35,310 $ 26,679 Contributions from joint venture partners 75,738 63,481 Currency translation adjustment (353 ) 1,398 Net assets $ 110,695 $ 91,558 November 1, 2020 December 31, 2019 December 31, 2018 Revenue $ 44,097 $ 62,341 $ 3,691 Cost of sales* (27,038 ) (15,067 ) (1,154 ) Gross margin 17,059 47,274 2,537 Selling, general and administrative expenses (8,717 ) (7,882 ) (2,584 ) Income (loss) from operations 8,342 39,392 (47 ) Interest expense (947 ) (884 ) (72 ) Foreign exchange gain (loss) (209 ) (9 ) (176 ) Write down of fixed assets — (144 ) — Other income, net** 4,223 26 18 Income (loss) before taxes 11,409 38,381 (277 ) Provision for income taxes (2,778 ) (10,967 ) 55 Net income (loss) $ 8,631 $ 27,414 $ (222 )

Investment In Joint Ventures _2

Investment In Joint Ventures And Minority Interests (Tables)	12 Months Ended
	Dec. 31, 2020
Village Fields Hemp USA LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Summary of summarized financial information	Summarized financial information of VF Hemp: December 31, 2020 December 31, 2019 Current assets Inventory $ 4,035 $ 9,308 Other current assets 302 546 Non-current assets 937 1,476 Current liabilities (1,472 ) (1,788 ) Non-current liabilities (13,697 ) (13,323 ) Net assets $ (9,895 ) $ (3,781 ) Reconciliation of net assets: Accumulated retained earnings $ (3,791 ) $ (3,791 ) Net loss for the year ended December 31, 2020 (6,114 ) — Contributions from joint venture partners 10 10 Net assets $ (9,895 ) $ (3,781 ) December 31, 2020 December 31, 2019 Revenue $ 348 $ 106 Cost of sales (482 ) (121 ) Depreciation (244 ) (111 ) General and administrative expenses (631 ) (869 ) Interest expense (345 ) (440 ) Write down of inventory (5,038 ) (2,356 ) Other 278 — Net loss $ (6,114 ) $ (3,791 )

Intangibles (Tables)

Intangibles (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Schedule of Acquired Intangible Assets	Acquired intangibles consist of the following: Classification December 31, 2020 Licenses $ 12,870 Branding 3,688 Computer software 945 Less: Accumulated amortization (192 ) Intangibles, net $ 17,311
Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets	The expected future amortization expense for definite-lived intangible assets as of December 31, 2020 is as follows: Fiscal period 2021 $ 777 2022 777 2023 771 2024 771 2025 680 Thereafter 9,847 Intangibles, net $ 13,623

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Debt	Balance outstanding as of December 31, 2020 2019 Term Loan - ("FCC Loan") - repayable by monthly principle of payments of $164 and accrued interest at a rate of 3.79%; matures April 1, 2025 $ 28,690 $ 31,306 Term Loan - VFCE: CA$3.0M - non-revolving fixed rate loan with fixed interest rate of 4.98%; matures June 2023 797 1,066 Advance on term loan - VFCE: CA$250 - repayable in monthly installments of principle plus interest rate of CA$ prime rate plus 200 basis points 69 106 Term Loan - Pure Sunfarms - CA$19.0M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount, interest rate of 4.2%; matures February, 2022 13,385 — Term loan - Pure Sunfarms - CA$25.0 - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50% of the outstanding principal amount starting June 30, 2021, interest rate of 4.2%; matures February 2022 16,535 — BDC Facility - Pure Sunfarms - non-revolving demand loan at prime interest plus 3.75% 4,905 — Unamortized deferred financing fees (302 ) (89 ) Total $ 64,079 $ 32,389
Schedule of maturities of long term debt	The aggregate annual principal maturities of long-term debt for the next five years and thereafter are as follows: 2021 $ 7,187 2022 29,909 2023 2,960 2024 2,760 2025 22,297 Thereafter 3,468 $ 68,581

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Payables And Accruals [Abstract]
Schedule of accrued liabilities	December 31, 2020 December 31, 2019 Accrued taxes $ 12,071 $ 527 Accrued payroll 2,865 296 Other 7,502 2,194 $ 22,438 $ 3,017

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Summary of lease related expenses	The components of lease related expenses are as follows: Year ended December 31, 2020 2019 Operating lease expense (a) $ 2,244 $ 2,410 Finance lease expense: Amortization of right-of-use assets 63 80 Interest on lease liabilities 4 7 Total finance lease expense $ 67 $ 87 (a) Includes short-term lease costs of $461 and $1,287 for the year ended December 31, 2020 and 2019
Schedule includes other information about leases	Cash paid for amounts included in the measurement of lease liabilities: Year ended December 31, 2020 2019 Operating cash flows from operating leases $ 1,150 $ 1,043 Operating cash flows from finance leases $ 4 $ — Financing cash flows from finance leases $ 63 $ 90 December 31, 2020 Weighted average remaining lease term: Operating leases 4.3 years Finance leases 1.2 years Weighted average discount rate: Operating leases 5.75 % Finance leases 6.25 %
Summary of maturities of lease liabilities	Maturities of lease liabilities are as follows: Operating leases Finance leases 2021 $ 1,304 $ 30 2022 1,090 9 2023 870 — 2024 512 — 2025 258 — Thereafter — — Undiscounted lease cash flow commitments 4,034 39 Reconciling impact from discounting (72 ) (4 ) Lease liabilities on consolidated balance sheet as of December 31, 2020 $ 3,962 $ 35

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Summary of income tax provision (recovery)	The components of the provision for (recovery of) income tax for the years ended December 31, 2020, 2019 and 2018 are as follows: 2020 Current Deferred Total US Federal $ — $ (4,879 ) $ (4,879 ) US State 260 (434 ) (174 ) Canadian 3,412 (1,149 ) 2,263 $ 3,672 $ (6,462 ) $ (2,790 ) 2019 Current Deferred Total US Federal $ — $ (5,922 ) $ (5,922 ) US State 8 (751 ) (743 ) Canadian (19 ) 818 799 $ (11 ) $ (5,855 ) $ (5,866 ) 2018 Current Deferred Total US Federal $ — $ (1,786 ) $ (1,786 ) US State 8 (187 ) (179 ) Canadian 422 (757 ) (335 ) $ 430 $ (2,730 ) $ (2,300 )
Summary of effective income tax rate reconciliation	The provision for (recovery of) income taxes reflected in the consolidated statements of (loss) income for the years ended December 31, 2020, 2019 and 2018 differs from the amounts computed at the federal statutory tax rates. The principal differences between the statutory income tax (recovery) and the effective provision for (recovery of) income taxes are summarized as follows: Year Ended December 31, 2020 2019 2018 Income (loss) before income taxes $ 8,818 $ (3,541 ) $ (9,815 ) Tax (recovery) calculated at US domestic tax rates 1,869 (744 ) (2,061 ) State tax adjustments (310 ) (350 ) — Non-deductible items (6,531 ) 1,304 394 True up of prior year income tax estimates (181 ) 207 (206 ) Capitalized debt amortization costs — (631 ) — Share of (income) losses from joint venture (228 ) (4,367 ) (75 ) Unrealized foreign exchange — (276 ) (309 ) Deferred adjustment 343 (1,920 ) — Differences attributed to joint venture capital transactions — (487 ) — Tax rate differences on deferred items 49 (42 ) (56 ) Differences in Canadian tax rates 1,643 1,472 92 Change in tax rates 37 — — Change in valuation allowance 3 (144 ) — Other 516 112 (79 ) Provision for (recovery of) income taxes $ (2,790 ) $ (5,866 ) $ (2,300 )
Summary of deferred tax assets and liabilities	Significant components of the Company’s net deferred income taxes at December 31, 2020 and 2019 are as follows: 2020 2019 Deferred tax assets: Other assets $ 4,935 $ 2,536 Long-term debt 897 1,040 Tax losses: Non-capital and farm losses 14,336 11,553 Provisions: Debt and unit issuance costs 1,355 800 Joint venture shares — 1,154 Tax losses: Valuation allowance (35 ) (31 ) 21,488 17,052 Deferred tax liabilities: Joint venture shares (2,651 ) (2,593 ) Cash adjustment (7,604 ) — Property, plant and equipment (15,980 ) (8,333 ) (26,235 ) (10,926 ) Net tax assets $ (4,747 ) $ 6,126

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Summary of net sales by the countries and property, plant and equipment, net of accumulated depreciation	The Company’s primary operations are in the United States and Canada. Segment information as of and for the years ended December 31, 2020, 2019 and 2018: 2020 2019 2018 Sales Produce $ 156,891 $ 143,419 $ 148,054 Cannabis – Canada 12,778 — — Energy – Canada 417 1,149 1,946 $ 170,086 $ 144,568 $ 150,000 Interest expense Produce $ 1,759 $ 2,543 $ 2,705 Cannabis – Canada 243 — — Energy – Canada 54 71 89 $ 2,056 $ 2,614 $ 2,794 Interest income Corporate $ 623 $ 1,036 $ 311 Cannabis – Canada 2 — — $ 625 $ 1,036 $ 311 Depreciation and amortization Produce $ 5,356 $ 6,462 $ 6,155 Cannabis – Canada 822 — — Energy – Canada 647 904 872 $ 6,825 $ 7,366 $ 7,027 Gross margin Produce $ 9,621 $ (6,667 ) $ 9,153 Cannabis – Canada 2,193 — — Energy – Canada (854 ) (678 ) 164 $ 10,960 $ (7,345 ) $ 9,317 Total assets 2020 2019 United States $ 110,107 $ 180,462 Canada 243,924 2,946 $ 354,031 $ 183,408 Property, plant and equipment, net 2020 2019 United States $ 56,011 $ 60,415 Canada 131,009 2,743 $ 187,020 $ 63,158

Income (Loss) Per Share (Tables

Income (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2020
Income Per Share [Abstract]
Summary of Basic and Diluted Net Income (Loss) per Ordinary Share	Basic net income (loss) per share is computed using the weighted average number of common shares outstanding for the period. Basic and diluted net income per ordinary share is calculated as follows (shares in thousands): For the Years Ended December 31, (shares in thousands) 2020 2019 2018 Numerator: Net income (loss) $ 11,608 $ 2,325 $ (7,515 ) Denominator: Weighted average number of common shares – Basic 58,526 49,418 44,357 Effect of dilutive securities – share-based employee options and awards 2,964 1,761 — Weighted average number of common shares – Diluted 61,490 51,179 44,357 Antidilutive options and awards (1) 500 310 2,175 Net income (loss) per ordinary share: Basic $ 0.20 $ 0.05 $ (0.17 ) Diluted $ 0.19 $ 0.05 $ (0.17 ) (1) Options to purchase shares of common stock and unvested RSUs are not included in the calculation of net income (loss) per share because the effect would have been anti-dilutive.

Shareholders Equity and Share_2

Shareholders Equity and Share Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Fair Value of Stock Option Valuation Assumptions	The following key assumptions were used in the valuation model to value stock option grants for each respective period: 2020 2019 2018 Expected volatility 71.1 % 60.7 % 55.5 % Dividend $nil $nil $nil Risk-free interest rate 0.52 % 1.86 % 2.30 % Expected life 7.1 years 5.7 years 5.9 years Fair value C$5.8314 C$9.7259 C$3.2541
Summary of Stock Based Compensation Stock Option	Stock option transactions under the Company’s plan for the years ended December 31, 2020, 2019 and 2018 are summarized as follows: Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value Outstanding at January 1, 2018 2,337,732 C$1.59 5.89 $ 14,125 Granted during 2018 203,000 C$5.79 9.44 Exercised during 2018 (365,733 ) C$0.98 2.68 Forfeited/expired during 2018 (10,000 ) C$1.48 Outstanding at December 31, 2018 2,164,999 C$2.10 5.69 $ 5,553 Exercisable at December 31, 2018 1,648,670 C$1.43 4.74 $ 5,012 Granted during 2019 510,000 C$16.32 9.19 Exercised during 2019 (212,332 ) C$1.29 4.85 Forfeited during 2019 (10,001 ) C$2.20 Outstanding at December 31, 2019 2,452,666 C$5.12 5.60 $ 11,435 Exercisable at December 31, 2019 1,707,337 C$1.78 4.18 $ 10,736 Granted 1,081,488 C$8.77 9.75 Exercised (425,166 ) C$1.36 1.62 Forfeited (41,666 ) C$6.93 — Outstanding at December 31, 2020 3,067,322 C$6.91 6.82 $ 20,051 Exercisable at December 31, 2020 1,618,168 C$3.91 4.58 $ 15,119
Schedule of Nonvested Stock Options Activity	A summary of the status of the Company’s non-vested stock options, and the changes during the year ended December 31, 2020, is presented below: Number of Options Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Non-vested at January 1, 2020 745,329 C$7.43 Granted 1,081,488 C$5.83 Vested (362,664 ) C$6.36 Forfeited (14,999 ) C$6.05 Non-vested at December 31, 2020 1,449,154 C$6.52 C$4,931
Summary of Performance Base Restricted Share Unit	Performance-based restricted share unit activity for the years ended December 31, 2020, 2019 and 2018 is as follows: Number of Performance-based Restricted Share Units Weighted Average Grant Date Fair Value Outstanding at January 1, 2018 128,000 C$2.82 Granted 979,000 C$5.79 Received (50,334 ) C$3.06 Forfeited/expired — — Outstanding at December 31, 2018 1,056,666 C$5.56 Exercisable at December 31, 2018 175,333 C$5.08 Granted 355,000 C$14.94 Issued (442,666 ) C$7.82 Forfeited (230,000 ) C$12.90 Outstanding at December 31, 2019 739,000 C$7.92 Exercisable at December 31, 2019 30,000 C$12.87 Granted 1,068,000 C$6.36 Exercised (840,000 ) C$6.47 Forfeited/expired (98,000 ) C$9.59 Outstanding at December 31, 2020 869,000 C$7.51 Exercisable at December 31, 2020 75,000 C$6.10
Summary of Non-Vested Performance-Based Restricted Share Units	A summary of the status of the Company’s non-vested performance-based restricted share units, and the changes during the year ended December 31, 2020, is presented below: Number of Performance-based Restricted Share Units Weighted Average Grant Date Fair Value Non-vested at January 1, 2020 709,000 C$7.72 Granted 1,068,000 C$6.36 Vested (885,000 ) C$6.93 Forfeited (98,000 ) C$9.59 Non-vested at December 31, 2020 794,000 C$7.33

Changes in Non-Cash Working C_2

Changes in Non-Cash Working Capital Items (Tables)	12 Months Ended
	Dec. 31, 2020
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Summary of Changes in Non Cash Working Capital Items	For the Years Ended December 31, 2020 2019 2018 Trade receivables $ (3,196 ) $ 2,301 $ (33 ) Inventories 2,997 9,042 (5,435 ) Note Receivable 765 — — Due from joint ventures 4,363 (3,530 ) — Other receivables 199 (448 ) 1,239 Prepaid expenses and deposits (1,245 ) (370 ) (79 ) Trade payables (1,665 ) (1,953 ) 1,649 Accrued liabilities 6,565 (369 ) (284 ) Other assets, net of other liabilities 4,289 571 (282 ) $ 13,072 $ 5,244 $ (3,225 )

Nature of Operations - Addition

Nature of Operations - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2020CAD ($)MW
Pure Sunfarms [Member]
Nature Of Operations [Line Items]
Wage subsidies received | $	$ 2,470
Village Fields Hemp USA LLC VF Hemp [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	65.00%
VF Clean Energy Inc [Member] | Power Plant [Member]
Nature Of Operations [Line Items]
Generation of Electricity | MW	7

Summary Of Significant Accounti

Summary Of Significant Accounting Policies - Estimated useful Lives of Intangible Assets (Detail)	12 Months Ended
	Dec. 31, 2020
Licenses [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	22 years
Brand [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	Indefinite
Computer Software [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	5 years

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2020USD ($)Segment	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Significant Accounting Policies [Line Items]
Number of reportable segments | Segment	3
Stock options vesting period	3 years
Stock options period of expiry	10 years
Description of uncertain position	The first step is recognition, where the Company evaluates whether an individual tax position has a likelihood of greater than 50% of being sustained upon examination based on the technical merits of the position, including resolution of any related appeals or litigation processes. For tax positions that are currently estimated to have a less than 50% likelihood of being sustained, zero tax benefit is recorded.
Maximum [Member]
Significant Accounting Policies [Line Items]
Percentage of tax position likely to be sustained	50.00%
Minimum [Member]
Significant Accounting Policies [Line Items]
Percentage of tax position likely to be sustained	50.00%
Share-based Payment Arrangement, Tranche One [Member]
Significant Accounting Policies [Line Items]
Stock options vesting percentage	33.00%
Share-based Payment Arrangement, Tranche Two [Member]
Significant Accounting Policies [Line Items]
Stock options vesting percentage	33.00%
Share-based Payment Arrangement, Tranche Three [Member]
Significant Accounting Policies [Line Items]
Stock options vesting percentage	33.00%
Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Significant Accounting Policies [Line Items]
Impairment charge | $	$ 0	$ 0	$ 0

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies - Summary of Estimated Useful Lives of Property Plant and Equipment (Detail)	12 Months Ended
	Dec. 31, 2020
Leaseholds and Leasehold Improvements [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	5 years
Leaseholds and Leasehold Improvements [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	20 years
Greenhouses and Other Buildings [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	4 years
Greenhouses and Other Buildings [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	30 years
Greenhouse Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	3 years
Greenhouse Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	30 years
Machinery and Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	3 years
Machinery and Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	20 years

Inventories - Summary of Invent

Inventories - Summary of Inventory Current (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Inventory [Line Items]
Inventories (note 4)	$ 46,599	$ 15,918
Available For Sale Inventory | Cannabis Business [Member]
Inventory [Line Items]
Inventories (note 4)	12,720
Distilled Oil | Cannabis Business [Member]
Inventory [Line Items]
Inventories (note 4)	13,511
Capitalized Production Costs | Cannabis Business [Member]
Inventory [Line Items]
Inventories (note 4)	3,438
Other | Cannabis Business [Member]
Inventory [Line Items]
Inventories (note 4)	2,552
Crop Inventory | Produce And Energy
Inventory [Line Items]
Inventories (note 4)	13,441	15,281
Purchased Produce | Produce And Energy
Inventory [Line Items]
Inventories (note 4)	810	530
Spare Parts Inventory | Produce And Energy
Inventory [Line Items]
Inventories (note 4)	$ 127	$ 107

Inventories - Additional inform

Inventories - Additional information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Crop Inventory
Inventory [Line Items]
Impairment loss on inventory	$ 0	$ 218

Property Plant And Equipment -

Property Plant And Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Property Plant And Equipment [Line Items]
Less: Accumulated depreciation	$ (91,991)	$ (80,206)
Property, plant and equipment, net	187,020	63,158
Land [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	10,447	3,204
Leaseholds and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	4,154	3,820
Building [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	142,060	72,772
Machinery and Equipment [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	69,390	61,871
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 52,960	$ 1,697

Property Plant And Equipment _2

Property Plant And Equipment - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Property Plant And Equipment [Abstract]
Depreciation on property,plant and equipment	$ 6,703	$ 7,366	$ 7,027

Business Combinations - Pure Su

Business Combinations - Pure Sunfarms Acquisition (Details)	Nov. 02, 2020USD ($)shares	Nov. 02, 2020CAD ($)	Mar. 31, 2019USD ($)shares	Nov. 02, 2020USD ($)shares	Dec. 31, 2020USD ($)	Dec. 31, 2020CAD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020CAD ($)	Nov. 02, 2020CAD ($)shares	Nov. 01, 2020USD ($)	Mar. 31, 2020	Mar. 02, 2020	Mar. 31, 2019CAD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Business Acquisition [Line Items]
Stockholders Equity					$ 205,283,000		$ 126,459,000							$ 84,433,000	$ 66,890,000
Retained Earnings [Member]
Business Acquisition [Line Items]
Stockholders Equity					35,858,000		24,250,000							$ 21,925,000	$ 29,440,000
Pure Sunfarms
Business Acquisition [Line Items]
Shares acquired accounted under equity method | shares			25,000,000
Fair value of assets of disposal groups			$ 18,700										$ 25,000
Gain on disposal of assets			$ 13,600
Additional equity transferred percent												2.50%
Additional Equity Interest Received Fair value					4,700,000			$ 6,500,000
Payment to acquire equity method investments					$ 11,700,000	$ 16,000,000
Equity method ownership percentage					58.70%			58.70%			57.40%
Emerald Health | Pure Sunfarms
Business Acquisition [Line Items]
Business Acquisition, Date of Acquisition Agreement	Nov. 2, 2020	Nov. 2, 2020
Business Acquisition, Name of Acquired Entity	Emerald Health Therapeutics Inc. (“Emerald”)	Emerald Health Therapeutics Inc. (“Emerald”)
Business Acquisition, Percentage of Voting Interests Acquired	100.00%			100.00%					100.00%
Business Combination, Consideration Transferred, Total	$ 60,000,000
Payments to Acquire Businesses	45,000,000
Promisonary Notes Payable	15,011,000			$ 15,011,000
Goodwill	$ 23,095,000
Gain on revaluation of previously held investment					$ 23,600,000
Emerald Health | Pure Sunfarms | Joint Venture
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired										58.70%
Investments							$ 41,300,000			$ 62,700,000
Emerald Health | Pure Sunfarms | Joint Venture | Hypothetical Liquidation Method Ownership [Member]
Business Acquisition [Line Items]
Percentage of earnings received from joint venture				58.70%			54.00%
Emerald Health | Pure Sunfarms | Retained Earnings [Member] | Joint Venture
Business Acquisition [Line Items]
Stockholders Equity					$ 16,276,000					$ 4,980,000
Emerald Health | Canada, Dollars | Pure Sunfarms
Business Acquisition [Line Items]
Business Combination, Consideration Transferred, Total		$ 79,900,000
Payments to Acquire Businesses		$ 60,000,000
Promisonary Notes Payable									$ 19,900,000
Common Stock [Member] | Emerald Health | Pure Sunfarms
Business Acquisition [Line Items]
Number of Shares acquired | shares	36,958,500			36,958,500					36,958,500

Business Combinations - Summary

Business Combinations - Summary of Assets and Liabilites (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2020	Nov. 02, 2020
ASSETS
Cash and cash equivalents		$ 10,860
Trade receivables, net		10,553
Inventories		32,393
Prepaid expenses and deposits		3,572
Property, plant and equipment		122,831
Goodwill (note 6)	$ 24,027	23,095
Intangibles		16,670
Total assets		219,974
LIABILITIES
Trade payables		3,849
Accrued liabilities		13,062
Income taxes payable		2,173
Current maturities of long-term debt		2,306
Deferred revenue		77
Long-term debt		23,903
Deferred tax liabilities		16,424
Total liabilities		61,794
Net assets acquired		158,180
Pure Sunfarms | Emerald Health
Business Acquisition [Line Items]
Cash		45,259
Promisonary Notes Payable		15,011
Shareholder loan		4,529
Promissory note owed to PSF from Emerald		439
Due to related party		$ 61
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Shares		52,569,197
Business Acquisition, Share Price		$ 1.767
Fair value of previously held investment shares held by Village Farms		$ 92,881
Total fair value of consideration		$ 158,180

Business Combinations - Summa_2

Business Combinations - Summary of Unaudited pro forma financials (Details) - Pure Sunfarms - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Net income (loss)	$ (1,817)	$ 31,475
Sales
Business Acquisition [Line Items]
Sales	$ 214,181	$ 206,909

Business Combinations - Summa_3

Business Combinations - Summary of Unaudited pro forma financials (Parenthetical) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Fair Value Adjustment to Inventory | Pure Sunfarms
Business Acquisition [Line Items]
Gain on revaluation of previously held investment	$ 23.6

Business Combinations - Summa_4

Business Combinations - Summary of company share of the joint venture (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Beginning Balance	$ 41,334
Ending Balance		$ 41,334
Pure Sunfarms
Beginning Balance	41,334	6,341
Investments in joint venture	16,393	18,717
Share of net income for the year	4,980	16,276
Ending Balance	$ 62,707	$ 41,334

Business Combinations - Summa_5

Business Combinations - Summary of summarized financial information (Details) - USD ($) $ in Thousands	Nov. 01, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current liabilities
Liabilities Current		$ 72,280	$ 22,029
Summary of Income Statement:
Sales (note 16)		170,086	144,568	$ 150,000
Gross margin (note 16)		10,960	(7,345)	9,317
Net income (loss)		$ 11,608	2,325	(7,515)
Pure Sunfarms
Current assets
Cash and cash equivalents	$ 10,804		7,356
Trade receivables	10,499		8,687
Inventory	33,330		21,745
Other current assets	4,234		6,964
Current liabilities
Trade payables	(3,829)		(4,938)
Borrowings due to joint ventures	(10,912)		(26,413)
Income taxes payable			(8,489)
Borrowings - current	(2,294)		(1,423)
Other current liabilities	15,381		5,021
Other current liabilities	(15,381)		(5,021)
Borrowings – long term	(23,780)		(13,089)
Deferred tax liability	(11,391)		(2,473)
Net assets	110,695		91,558
Reconciliation of net assets:
Accumulated retained earnings	35,310		26,679
Contributions from joint venture partners	75,738		63,481
Currency translation adjustment	(353)		1,398
Net assets	110,695		91,558
Summary of Income Statement:
Selling, general and administrative expenses	(8,717)		(7,882)	(2,584)
Interest expense	(947)		(884)	(72)
Foreign exchange gain (loss)	(209)		(9)	(176)
Write down of fixed assets			(144)
Other income, net	4,223		26	18
Income (loss) before taxes	11,409		38,381	(277)
Provision for income taxes	(2,778)		(10,967)	55
Pure Sunfarms | Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Current assets
Non-current assets	119,415		108,652
Summary of Income Statement:
Sales (note 16)	44,097		62,341	3,691
Cost of sales	(27,038)		(15,067)	(1,154)
Gross margin (note 16)	17,059		47,274	2,537
Income (loss) from operations	8,342		39,392	(47)
Net income (loss)	$ 8,631		$ 27,414	$ (222)

Business Combinations - Summa_6

Business Combinations - Summary of summarized financial information (Parenthetical) (Details) - USD ($) $ in Thousands	Nov. 01, 2020	Dec. 31, 2019	Dec. 31, 2018
Business Combinations [Abstract]
Depreciation Expense	$ 3,120	$ 2,671	$ 796

Investment In Joint Ventures _3

Investment In Joint Ventures And Minority Interests - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Feb. 27, 2019	Dec. 31, 2020	Dec. 31, 2019	Aug. 31, 2020	Jul. 31, 2020	May 21, 2019
Dutch Can Grow Inc [Member]
Investment in minority interest					$ 226
Percentage of minority interest ownership					16.00%
Altum International Pty Ltd
Investment in minority interest				$ 1,000
Percentage of minority interest ownership				6.60%
Altum International Pty Ltd | Maximum [Member]
Equity ownership percentage				10.00%
Village Fields Hemp USA LLC [Member]
Note receivable to joint ventures	$ 15,000
Arkansas Valley Green and Gold Hemp [Member]
Investments write off			$ 1,184
Village Farms International [Member]
Equity ownership percentage						60.00%
Village Farms International [Member] | VF Hemp [Member]
Equity ownership percentage	65.00%	65.00%
Financing receivable, allowance for credit loss, recovery		$ 3,545
Nature Crisp [Member] | VF Hemp [Member]
Equity ownership percentage	35.00%
VF Hemp [Member] | Grid Loan Agreement [Member]
Grid loan to joint venture		$ 3,545
Debt Instrument Maturity Date		Mar. 25, 2022
Simple interest rate on funds advanced		8.00%
Loan wrote off		$ 3,791
Inventory write off on net realizable value and recognized loss		$ 5,163
Arkansas Valley Hemp [Member]
Equity ownership percentage						35.00%
Village Fields Hemp USA LLC [Member]
Equity ownership percentage						5.00%

Investment In Joint Ventures _4

Investment In Joint Ventures And Minority Interests - Summary of summarized financial information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current liabilities
Current liabilities	$ (72,280)	$ (22,029)
Summary of Income Statement:
Net income (loss)	11,608	2,325	$ (7,515)
Sales (note 16)	170,086	144,568	150,000
Depreciation	(6,703)	(7,366)	(7,027)
Net income (loss)	11,608	2,325	$ (7,515)
Village Fields Hemp USA LLC [Member]
Current assets
Inventory	4,035	9,308
Other current assets	302	546
Current liabilities
Deferred tax liability	(13,697)	(13,323)
Net assets	(9,895)	(3,781)
Reconciliation of net assets:
Accumulated retained earnings	(3,791)	(3,791)
Summary of Income Statement:
Net income (loss)	(6,114)	(3,791)
Contributions from joint venture partners	10	10
Net assets	(9,895)	(3,781)
Sales (note 16)	348	106
Cost of sales	(482)	(121)
Depreciation	(244)	(111)
Selling, general and administrative expenses	(631)	(869)
Interest expense	(345)	(440)
Write down of inventory	(5,038)	(2,356)
Other	278
Net income (loss)	(6,114)	(3,791)
Village Fields Hemp USA LLC [Member] | Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]
Current assets
Non-current assets	937	1,476
Current liabilities
Current liabilities	$ (1,472)	$ (1,788)

Intangibles - Schedule of Acqui

Intangibles - Schedule of Acquired Intangible Assets (Detail) $ in Thousands	Dec. 31, 2020USD ($)
Finite Lived Intangible Assets [Line Items]
Less: Accumulated amortization	$ (192)
Intangibles, net	17,311
Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	12,870
Branding [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	3,688
Computer Software [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	$ 945

Intangibles - Schedule of Expec

Intangibles - Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets (Detail) $ in Thousands	Dec. 31, 2020USD ($)
Fiscal period
2021	$ 777
2022	777
2023	771
2024	771
2025	680
Thereafter	9,847
Intangibles, net	$ 13,623

Intangibles - Additional (Detai

Intangibles - Additional (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Goodwill And Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 122

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Term Loan	$ 64,079	$ 32,389
Unamortized deferred financing fees	(302)	(89)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Term Loan	28,690	31,306
Term Loan (VFCE) [Member]
Debt Instrument [Line Items]
Term Loan	797	1,066
Advance On Term Loan VFCE [Member]
Debt Instrument [Line Items]
Term Loan	69	$ 106
Term Loan One [Member] | Pure Sunfarms
Debt Instrument [Line Items]
Term Loan	13,385
Term Loan Two [Member] | Pure Sunfarms
Debt Instrument [Line Items]
Term Loan	16,535
BDC Facility [Member] | Pure Sunfarms
Debt Instrument [Line Items]
Term Loan	$ 4,905

Debt - Schedule of Debt (Parent

Debt - Schedule of Debt (Parenthetical) (Detail) - 12 months ended Dec. 31, 2020 $ in Millions, $ in Millions	USD ($)	CAD ($)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment	$ 164
Debt instrument, interest rate during period	3.79%	3.79%
Debt Instrument Maturity Date	Apr. 1, 2025	Apr. 1, 2025
Term Loan (VFCE) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 3
Debt instrument, interest rate during period	4.98%	4.98%
Debt Instrument Maturity Date	Jun. 30, 2023	Jun. 30, 2023
Advance On Term Loan VFCE [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 250
Debt instrument, basis point	200	200
Term Loan One [Member] | Pure Sunfarms
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 19
Debt instrument, interest rate during period	4.20%	4.20%
Debt Instrument Maturity Date	Feb. 28, 2022	Feb. 28, 2022
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Term Loan Two [Member] | Pure Sunfarms
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 25
Debt instrument, interest rate during period	4.20%	4.20%
Debt Instrument Maturity Date	Feb. 28, 2022	Feb. 28, 2022
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Debt instrument, maturity start date	Jun. 30, 2021	Jun. 30, 2021
BDC Facility [Member] | Pure Sunfarms
Debt Instrument [Line Items]
Debt instrument, interest rate during period	3.75%	3.75%

Debt - Additional Information (

Debt - Additional Information (Detail)	Apr. 02, 2020USD ($)	Apr. 02, 2020CAD ($)	Feb. 07, 2019USD ($)	Feb. 07, 2019CAD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020CAD ($)	Nov. 02, 2020USD ($)	Jun. 30, 2020USD ($)
Disclosure Of Borrowings [Line Items]
Weighted average interest rate					5.11%	6.20%	5.11%
Trade payables								$ 3,849,000
Accounts Payable and Accrued Liabilities [Member]
Disclosure Of Borrowings [Line Items]
Accrued interest payable					$ 189,000	$ 162,000
Pure Sunfarms | Agreement [Member]
Disclosure Of Borrowings [Line Items]
Trade payables					15,200,000		$ 19,900,000
Non-Revolving Variable Rate Term Loan 2021 [Member] | FCC Loan [Member]
Disclosure Of Borrowings [Line Items]
Securities pledged as collateral					86,664,000	155,548,000
Revolving Operating Loan [Member]
Disclosure Of Borrowings [Line Items]
Maximum borrowing capacity							13,000
Line of credit outstanding					150,000,000		38,000,000
Amounts drawn on facility					2,000	2,000
Securities pledged as collateral					23,443,000	$ 24,915,000
Revolving Operating Loan [Member] | Pure Sunfarms
Disclosure Of Borrowings [Line Items]
Maximum borrowing capacity									$ 15,000,000
Line of credit outstanding					4,039,000
Advance line of credit facility					0
Term Loan One [Member]
Disclosure Of Borrowings [Line Items]
Debt instrument periodic payment			$ 13,300,000	$ 17,500
Term Loan Two [Member]
Disclosure Of Borrowings [Line Items]
Debt instrument periodic payment	$ 16,500,000	$ 22,500,000
Non Revolving Demand Loan [Member]
Disclosure Of Borrowings [Line Items]
Maximum borrowing capacity							$ 6,250,000
Line of credit outstanding					$ 4,905,000
Weighted average interest rate					3.75%		3.75%

Debt - Summary of Aggregate Ann

Debt - Summary of Aggregate Annual Maturities of Long-Term Debt (Detail) $ in Thousands	Dec. 31, 2020USD ($)
Debt Disclosure [Abstract]
2021	$ 7,187
2022	29,909
2023	2,960
2024	2,760
2025	22,297
Thereafter	3,468
Long-term debt	$ 68,581

Accrued Liabilities - Schedule

Accrued Liabilities - Schedule of accrued liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Payables And Accruals [Abstract]
Accrued taxes	$ 12,071	$ 527
Accrued payroll	2,865	296
Other	7,502	2,194
Accrued liabilities	$ 22,438	$ 3,017

Leases - Summary Of Lease Relat

Leases - Summary Of Lease Related Expenses (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Short-term lease costs	$ 461	$ 1,287

Leases - Summary Of Lease Rel_2

Leases - Summary Of Lease Related Expenses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease expense	[1]	$ 2,244	$ 2,410
Amortization of right-of-use assets		63	80
Interest on lease liabilities		4	7
Total finance lease expense		$ 67	$ 87
[1]	Includes short-term lease costs of $461 and $1,287 for the year ended December 31, 2020 and 2019

Leases - Schedule Includes Othe

Leases - Schedule Includes Other Information About Leases (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating cash flows from operating leases	$ 1,150	$ 1,043
Operating cash flows from finance leases	4
Financing cash flows from finance leases	$ 63	$ 90
Weighted average remaining lease term:
Operating leases	4 years 3 months 18 days
Finance leases	1 year 2 months 12 days
Weighted average discount rate:
Operating leases	5.75%
Finance leases	6.25%

Leases - Summary of maturities

Leases - Summary of maturities of lease matirities (Detail) $ in Thousands	Dec. 31, 2020USD ($)
Operating Leases [Member]
2021	$ 1,304
2022	1,090
2023	870
2024	512
2025	258
Undiscounted lease cash flow commitments	4,034
Reconciling impact from discounting	(72)
Lease liabilities on consolidated balance sheet as of December 31, 2020	3,962
Finance Leases [Member]
2021	30
2022	9
Undiscounted lease cash flow commitments	39
Reconciling impact from discounting	(4)
Lease liabilities on consolidated balance sheet as of December 31, 2020	$ 35

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Financial Instruments Owned And Pledged As Collateral [Line Items]
Fair value transfers between levels	$ 0	$ 0
Fair Value Inputs Level 3 [Member]
Financial Instruments Owned And Pledged As Collateral [Line Items]
Financial instruments net	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)
Pure Sunfarms
Loss Contingencies [Line Items]
Event commitment of a service agreement break up	$ 1,000

Related Party Transactions an_2

Related Party Transactions and Balances - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Related Party Transaction [Line Items]
Salary and benefits to employee	$ 118	$ 110	$ 115
Outstanding loan balance repaid by employee	124
Employee Relocation [Member]
Related Party Transaction [Line Items]
Relocation expense	249
Grid Loan Agreement [Member]
Related Party Transaction [Line Items]
Loans receivable, related parties	$ 3,545	10,865
VF Hemp [Member]
Related Party Transaction [Line Items]
Debt securities maturity date	Mar. 25, 2022
Loan interest rate percentage	8.00%
Loan wrote off	$ 3,791	3,545
AVGG Hemp [Member]
Related Party Transaction [Line Items]
Loan interest rate percentage	8.00%
Loans receivable, related parties	$ 5,000
Loan wrote off		1,184
Grid loan to joint venture		$ 1,184

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Provision (Recovery) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax [Line Items]
Current	$ 3,672	$ (11)	$ 430
Deferred	(6,462)	(5,855)	(2,730)
Provision For (Recovery Of) Income Taxes	(2,790)	(5,866)	(2,300)
US State [Member]
Income Tax [Line Items]
Current	260	8	8
Deferred	(434)	(751)	(187)
Provision For (Recovery Of) Income Taxes	(174)	(743)	(179)
Canadian [Member]
Income Tax [Line Items]
Current	3,412	(19)	422
Deferred	(1,149)	818	(757)
Provision For (Recovery Of) Income Taxes	2,263	799	(335)
US Federal [Member]
Income Tax [Line Items]
Deferred	(4,879)	(5,922)	(1,786)
Provision For (Recovery Of) Income Taxes	$ (4,879)	$ (5,922)	$ (1,786)

Income Taxes - Summary of Effec

Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax [Line Items]
Income (loss) before income taxes	$ 8,818	$ (3,541)	$ (9,815)
Tax (recovery) calculated at US domestic tax rates	1,869	(744)	(2,061)
State tax adjustments	(310)	(350)
Non-deductible items	(6,531)	1,304	394
True up of prior year income tax estimates	(181)	207	(206)
Capitalized debt amortization costs		(631)
Share of (income) losses from joint venture	(228)	(4,367)	(75)
Unrealized foreign exchange		(276)	(309)
Deferred adjustment	343	(1,920)
Differences attributed to joint venture capital transactions		(487)
Tax rate differences on deferred items	49	(42)	(56)
Change in tax rates	37
Change in valuation allowance	3	(144)
Other	516	112	(79)
Provision For (Recovery Of) Income Taxes	(2,790)	(5,866)	(2,300)
Canadian [Member]
Income Tax [Line Items]
Differences in Canadian tax rates	1,643	1,472	92
Provision For (Recovery Of) Income Taxes	$ 2,263	$ 799	$ (335)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Tax [Line Items]
Federal statutory tax rate of Canada	27.00%	27.00%	27.00%
Federal statutory tax rate of United States	21.00%	21.00%	21.00%
Effective tax rate	(31.40%)	165.60%	23.40%
Valuation allowance	$ 35	$ 31	$ 504
Net operating losses carry forwards	$ 58,780	48,285
Operating loss carry forwards, expiration year	2031
Uncertain tax benefits	$ 0	0
Income Tax Penalties and Interest	0	0
State and Local Jurisdiction [Member]
Income Tax [Line Items]
Net operating losses carry forwards	$ 21,108	12,572
Operating loss carry forwards, expiration year	2020
Foreign Tax Authority [Member]
Income Tax [Line Items]
Net operating losses carry forwards	$ 3,345	$ 1,770
Operating loss carry forwards, expiration year	2027

Income Taxes - Summary of Defer

Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets:
Other assets	$ 4,935	$ 2,536
Long-term debt	897	1,040
Tax losses: Non-capital and farm losses	14,336	11,553
Provisions: Debt and unit issuance costs	1,355	800
Joint venture shares		1,154
Tax losses: Valuation allowance	(35)	(31)
Total deferred tax assets	21,488	17,052
Total deferred tax assets	21,488	17,052
Deferred tax liabilities:
Joint venture shares	(2,651)	(2,593)
Cash adjustment	(7,604)
Property, plant and equipment	(15,980)	(8,333)
Total deferred tax liabilities	(26,235)	(10,926)
Net tax assets		$ 6,126
Net tax liabilities	$ (4,747)

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2020SegmentCustomer	Dec. 31, 2019Customer
Segment Reporting Information [Line Items]
Number of operating segments | Segment	3
Revenue Benchmark [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	79.00%	83.00%
Number of major customers	2	3
Revenue Benchmark [Member] | United States [Member] | Minimum [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	10.00%	10.00%
Revenue Benchmark [Member] | Publix Super Markets [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	12.70%	11.80%
Revenue Benchmark [Member] | Walmart [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	12.50%	10.90%
Revenue Benchmark [Member] | Kroger [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage		10.60%
Accounts Receivable [Member]
Segment Reporting Information [Line Items]
Number of major customers	2	1
Accounts Receivable [Member] | Minimum [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	10.00%	10.00%
Accounts Receivable [Member] | Major Customer One [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	26.30%
Accounts Receivable [Member] | Major Customer [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage		16.90%

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of net sales by the countries and property, plant and equipment, net of accumulated depreciation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenues [Abstract]
Revenues	$ 170,086	$ 144,568	$ 150,000
Interest expense [Abstract]
Interest expense	2,056	2,614	2,794
Interest income [Abstract]
Interest income (note 16)	625	1,036	311
Interest income	625	1,036	311
Depreciation and amortization [Abstract]
Depreciation and amortization	6,825	7,366	7,027
Gross margin [Abstract]
Gross margin	10,960	(7,345)	9,317
ASSETS
Assets	354,031	183,408
Property, plant and equipment, net [Abstract]
Property, plant and equipment, net	187,020	63,158
Produce Business [Member]
Revenues [Abstract]
Revenues	156,891	143,419	148,054
Interest expense [Abstract]
Interest expense	1,759	2,543	2,705
Depreciation and amortization [Abstract]
Depreciation and amortization	5,356	6,462	6,155
Gross margin [Abstract]
Gross margin	9,621	(6,667)	9,153
Canada [Member]
ASSETS
Assets	243,924	2,946
Property, plant and equipment, net [Abstract]
Property, plant and equipment, net	131,009	2,743
Canada [Member] | Cannabis Business [Member]
Revenues [Abstract]
Revenues	12,778
Interest expense [Abstract]
Interest expense	243
Interest income [Abstract]
Interest income (note 16)	2
Interest income	2
Depreciation and amortization [Abstract]
Depreciation and amortization	822
Gross margin [Abstract]
Gross margin	2,193
Canada [Member] | Energy Business [Member]
Revenues [Abstract]
Revenues	417	1,149	1,946
Interest expense [Abstract]
Interest expense	54	71	89
Depreciation and amortization [Abstract]
Depreciation and amortization	647	904	872
Gross margin [Abstract]
Gross margin	(854)	(678)	164
Corporate [Member]
Interest income [Abstract]
Interest income (note 16)	623	1,036	311
Interest income	623	1,036	$ 311
United States [Member]
ASSETS
Assets	110,107	180,462
Property, plant and equipment, net [Abstract]
Property, plant and equipment, net	$ 56,011	$ 60,415

Income (Loss) Per Share - Basic

Income (Loss) Per Share - Basic And Diluted Net Income (loss) Per Ordinary Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Numerator:
Net income (loss)		$ 11,608	$ 2,325	$ (7,515)
Denominator:
Weighted average number of common shares – Basic		58,526	49,418	44,357
Effect of dilutive securities – share-based employee options and awards		2,964	1,761
Weighted average number of common shares – Diluted		61,490	51,179	44,357
Antidilutive options and awards	[1]	500	310	2,175
Net income (loss) per ordinary share:
Basic		$ 0.20	$ 0.05	$ (0.17)
Diluted		$ 0.19	$ 0.05	$ (0.17)
[1]	Options to purchase shares of common stock and unvested RSUs are not included in the calculation of net income (loss) per share because the effect would have been anti-dilutive.

Shareholders Equity and Share_3

Shareholders Equity and Share Based Compensation - Additional Information (Detail) $ / shares in Units, $ in Thousands	Sep. 10, 2020USD ($)$ / sharesshares	Dec. 31, 2020USD ($)shares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)	Dec. 31, 2019$ / shares	Dec. 31, 2018USD ($)	Dec. 31, 2018$ / shares
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Shares issued in pubic offering, net of issuance costs (in shares) | shares	9,396,226
Purchase price | $ / shares	$ 5.30
Proceeds from issuance of common stock	$ 49,800
Description of units sold	Each unit that was sold consists of one common share of the Company and a one-half (0.5) of a warrant to purchase a common share of the Company
Class of warrant or right, exercise price of warrants or rights | $ / shares	$ 5.80
Warrants exercisable beginning date	Mar. 10, 2021
Warrants exercisable expiration date	Sep. 10, 2025
Option granted contractual term		10 years
Stock options vesting period		3 years
Weighted average grant date fair value | $ / shares			$ 5.83		$ 9.58		$ 3.22
Aggregate Intrinsic value exercised		$ 2,732		$ 1,999		$ 2,162
Unrecognized share based compensation expense		$ 9,449	$ 9,449
Share based compensation cost expected period for recognition		3 years
Share based compensation expense		$ 6,142		$ 4,714		$ 1,454
Stock Compensation Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Number of shares available for issuance | shares		2,175,000	2,175,000
Maximum percentage of outstanding shares		10.00%

Shareholders Equity and Share_4

Shareholders Equity and Share Based Compensation - Summary of Fair Value Assigned To The Option Issues (Detail)	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2020$ / shares	Dec. 31, 2019$ / shares	Dec. 31, 2018$ / shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Expected volatility	71.10%	60.70%	55.50%
Dividend | $
Risk-free interest rate	0.52%	1.86%	2.30%
Expected life	7 years 1 month 6 days	5 years 8 months 12 days	5 years 10 months 24 days
Fair value | $ / shares				$ 5.8314	$ 9.7259	$ 3.2541

Shareholders Equity and Share_5

Shareholders Equity and Share Based Compensation - Summary of Stock Option (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)shares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)shares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2018USD ($)shares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2017USD ($)shares	Dec. 31, 2020$ / shares	Dec. 31, 2019$ / shares	Dec. 31, 2018$ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted Average Remaining Contractual Term (years), Beginning balance	10 years
Stock Option [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Beginning balance | shares	2,452,666		2,164,999		2,337,732
Number of Options, Granted | shares	1,081,488		510,000		203,000
Number of Options, Exercised | shares	(425,166)		(212,332)		(365,733)
Number of Options, Forfeited/expired | shares					(10,000)
Number of Options, Forfeited | shares	(41,666)		(10,001)
Number of Options, Ending balance | shares	3,067,322		2,452,666		2,164,999		2,337,732
Number of Options, Exercisable | shares	1,618,168	1,618,168	1,707,337	1,707,337	1,648,670	1,648,670
Weighted Average Exercise Price, Beginning balance | $ / shares		$ 5.12		$ 2.10		$ 1.59
Weighted Average Exercise Price, Granted | $ / shares		8.77		16.32		5.79
Weighted Average Exercise Price, Exercised | $ / shares		1.36		1.29		0.98
Weighted Average Exercise Price, Forfeited/expired | $ / shares						1.48
Weighted Average Exercise Price, Forfeited | $ / shares		6.93		2.20
Weighted Average Exercise Price, Ending balance | $ / shares		$ 6.91		$ 5.12		$ 2.10
Weighted Average Exercise Price, Exercisable | $ / shares								$ 3.91	$ 1.78	$ 1.43
Weighted Average Remaining Contractual Term (years), Beginning balance	6 years 9 months 25 days		5 years 7 months 6 days		5 years 8 months 8 days		5 years 10 months 20 days
Weighted Average Remaining Contractual Term (years), Granted	9 years 9 months		9 years 2 months 8 days		9 years 5 months 8 days
Weighted Average Remaining Contractual Term (years), Exercised	1 year 7 months 13 days		4 years 10 months 6 days		2 years 8 months 4 days
Weighted Average Remaining Contractual Term (years), Exercisable	4 years 6 months 29 days		4 years 2 months 4 days		4 years 8 months 26 days
Aggregate Intrinsic Value, Beginning balance | $	$ 11,435		$ 5,553		$ 14,125
Aggregate Intrinsic Value, Ending balance | $	20,051		11,435		5,553		$ 14,125
Aggregate Intrinsic Value, Exercisable | $	$ 15,119	$ 15,119	$ 10,736	$ 10,736	$ 5,012	$ 5,012

Shareholders Equity and Share_6

Shareholders Equity and Share Based Compensation - Summary of Non-vested Stock Option (Detail) - CAD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Beginning balance	745,329
Granted	1,081,488
Vested	(362,664)
Forfeited	(14,999)
Ending balance	1,449,154	745,329
Beginning balance	$ 7.43
Granted	5.83	$ 9.58	$ 3.22
Vested	6.36
Forfeited	6.05
Ending balance	$ 6.52	$ 7.43
Ending balance	$ 4,931

Shareholders Equity and Share_7

Shareholders Equity and Share Based Compensation - Summary of Performance base restricted share unit activity (Detail) - Performance-Based Restricted Share Unit [Member] - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Number of Performance-based Restricted Share Units, Beginning balance	739,000	1,056,666	128,000
Number of Performance-based Restricted Share Units, Granted	1,068,000	355,000	979,000
Number of Performance-based Restricted Share Units, Received			50,334
Number of Performance-based Restricted Share Units, Forfeited		(230,000)
Number of Performance-based Restricted Share Units, Exercised	(840,000)
Number of Performance-based Restricted Share Units, Forfeited/expired	(98,000)
Number of Performance-based Restricted Share Units, Ending balance	869,000	739,000	1,056,666
Number of Performance-based Restricted Share Units, Exercisable	75,000	30,000	175,333
Number of Performance-based Restricted Share Units, Forfeited		230,000
Number of Performance-based Restricted Share Units, Exercised	840,000
Number of Performance-based Restricted Share Units, Forfeited/expired	98,000
Weighted Average Grant Date Fair Value, Beginning balance	$ 7.92	$ 5.56	$ 2.82
Weighted Average Grant Date Fair Value, Granted	6.36	14.94	5.79
Weighted Average Grant Date Fair Value, Received			3.06
Weighted Average Grant Date Fair Value, Forfeited		12.90
Weighted Average Grant Date Fair Value, Exercised	6.47
Weighted Average Grant Date Fair Value, Forfeited/expired	9.59
Weighted Average Grant Date Fair Value, Ending balance	7.51	7.92	5.56
Weighted Average Grant Date Fair Value, Exercisable	$ 6.10	$ 12.87	$ 5.08
Exercise price in CA$7.82
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Number of Performance-based Restricted Share Units, Granted		442,666
Weighted Average Grant Date Fair Value, Granted		$ 7.82

Shareholders Equity and Share_8

Shareholders Equity and Share Based Compensation - Summary of Non-vested Performance-Based Restricted Share units (Detail)	12 Months Ended
	Dec. 31, 2020$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted	1,081,488
Non-Vested Performance-Based Restricted Share Units [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Performance-based Restricted Share Units, Beginning balance	709,000
Granted	1,068,000
Vested	(885,000)
Forfeited	(98,000)
Number of Performance-based Restricted Share Units, Ending balance	794,000
Weighted Average Grant Date Fair Value, Beginning balance | $ / shares	$ 7.72
Weighted Average Grant Date Fair Value, Granted | $ / shares	6.36
Weighted Average Grant Date Fair Value, Vested | $ / shares	6.93
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	9.59
Weighted Average Grant Date Fair Value, Ending balance | $ / shares	$ 7.33

Changes in Non Cash Working Cap

Changes in Non Cash Working Capital Items - (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Trade receivables	$ (3,196)	$ 2,301	$ (33)
Inventories	2,997	9,042	(5,435)
Note Receivable	765
Due from joint ventures	4,363	(3,530)
Other receivables	199	(448)	1,239
Prepaid expenses and deposits	(1,245)	(370)	(79)
Trade payables	(1,665)	(1,953)	1,649
Accrued liabilities	6,565	(369)	(284)
Other assets, net of other liabilities	4,289	571	(282)
Total	$ 13,072	$ 5,244	$ (3,225)

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Thousands	Mar. 10, 2021shares	Feb. 05, 2021USD ($)shares	Feb. 05, 2021CAD ($)shares	Jan. 20, 2021USD ($)$ / sharesshares	Jan. 20, 2021CAD ($)shares	Sep. 10, 2020$ / sharesshares	Feb. 05, 2021CAD ($)	Jan. 20, 2021$ / sharesshares	Dec. 31, 2020shares	Dec. 31, 2019shares
Subsequent Event [Line Items]
Purchase price | $ / shares						$ 5.30
Common Stock, Shares, Outstanding									66,911,811	52,656,669
Common Stock, Shares, Issued									66,911,811	52,656,669
Shares issued in pubic offering, net of issuance costs (in shares)						9,396,226
Class of warrant or right, exercise price of warrants or rights | $ / shares						$ 5.80
Warrants exercisable beginning date						Mar. 10, 2021
Warrants exercisable expiration date						Sep. 10, 2025
Description of units sold						Each unit that was sold consists of one common share of the Company and a one-half (0.5) of a warrant to purchase a common share of the Company
Subsequent Event [Member]
Subsequent Event [Line Items]
Common Stock, Shares, Outstanding				77,798,908				77,798,908
Common Stock, Shares, Issued				77,798,908				77,798,908
Accrued interest		$ 487					$ 622
Subsequent Event [Member] | Warrant [Member]
Subsequent Event [Line Items]
Stock issued during period shares stock options exercised	1,773,585
Subsequent Event [Member] | Agreement [Member]
Subsequent Event [Line Items]
Payment of Promissory Note		$ 15,600	$ 19,900
Subsequent Event [Member] | Pure Sunfarms | Agreement [Member]
Subsequent Event [Line Items]
Shares acquired accounted under equity method		36,958,500	36,958,500
Private Placement [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Sale of Stock, Number of Shares Issued in Transaction				10,887,097	10,887,097
Purchase price | (per share)				$ 12.40				$ 15.70
Sale of Stock, Consideration Received on Transaction				$ 135,000	$ 171,000